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| Chapter 1 
PRIMORDIAL GERM CELLS AND GAMETOGENESIS IN HUMANS AND MICE 
The immortal life cycle of mammalian germ cells
In mammals, germ cells are immortal and highly specialized for transmitting genetic 
information through generations [1, 2]. Following the segregation of the germline from the 
somatic lineage early in embryogenesis [3], primordial germ cells (PGCs), the progenitors of 
haploid gametes, originate outside the early post-implantation embryo at the border with the 
extraembryonic part of the embryo. The PGCs then migrate across the embryo to reach the 
developing gonad [4, 5]. Through spermatogenesis or oogenesis in the gonads, PGCs differentiate 
into sperms or oocytes via meiosis (Figure 1) [3]. Following the fusion of sperm with an mature 
oocyte, the haploid genomes of each parent are unified, resulting in a totipotent one-cell zygote 
[6]. The zygote, which represents the earliest developmental stage of embryogenesis, will develop 
into an embryo and eventually a complete organism together with all of its extraembryonic 
structures [7]. These extraembryonic structures mediate implantation in the uterine wall and 
the following gas exchange and nutrient supply. From the post-implantation epiblast, PGCs are 
specified [8-10].
Origin and migration of human and mouse PGCs
Due to the limited access to very early human embryos and more importantly restrictions 
to the allowed time in culture (14 days), little is known about PGCs formation in humans 
[10]. During weeks 5-6 of gestation (W5-W6, or weeks 3-4 post conception), PGCs are 
observed in human embryos in the yolk sac wall close to the allantois [11]. Subsequently, they 
migrate through the dorsal hind gut mesentery to the gonadal primordia [12] and arrive at the 
prospective ovary or testis around W7 [13]. By contrast, mouse PGC precursors are known to 
be induced in epiblast-derived embryonic ectoderm at embryonic day (E)6.25, located between 
extraembryonic and embryonic ectoderm [14]. At E7.25, PGCs are present at the base of the 
mesodermal allantois [10, 15]. From there they migrate through the developing hindgut, along 
the midline of the embryo, and reach the genital ridges at around E10.5 [4, 16]. However, some 
PGCs may stop migrating on their way to the gonads or become lodged in extragonadal organs 
such as adrenal glands [17, 18]. Ectopic PGCs are often associated with extragonadal germ cell 
tumors in humans [19]. Therefore, the development of human extragonadal PGCs and their fate 
deserve further investigation. 
Gametogenesis in humans and mice
Following gonadal colonization, both human and mouse PGCs differentiate into oogonia 
in females and spermatogonia in males upon sex determination [10, 20]. In the female ovaries, 
after mitotic arrest, oogonia enter meiotic prophase as primary oocytes and after birth arrest 
at the diplotene stage of meiosis [21]. After puberty, hormonal stimulation during ovulation 
of each menstrual cycle causes maturation and release of the dominant oocyte. After the first 
meiotic division is completed, the mature oocyte arrests at metaphase II stage, ready to be 
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fertilized [22, 23]. In the male testes, spermatogonia proliferate and then arrest in the G0/G1 
phase of the mitotic division [24]. In contrast to females, male germ cells do not enter meiosis 
before birth [25]. After birth, the germ cells resume mitotic proliferation. Until puberty, some 
of spermatogonia in the seminiferous tubules enter meiosis I and differentiate into primary 
spermatocytes. Secondary spermatocytes are produced after meiosis I and then after the second 
meiotic division, haploid spermatids are formed. These spermatids subsequently differentiate 
morphologically into sperms through changes in cellular organization and shape [26]. 
PRE-IMPLANTATION DEVELOPMENT AND IMPLANTATION IN HUMANS AND 
MICE
 The pre-implantation development period, which includes fertilization, cell cleavage, 
morula and blastocyst formation, comprises the initial stages of mammalian development. It takes 
place before the embryo implants into the mother’s uterus (Figure 2) [27]. Fertilization represents 
one of the most important and fascinating processes in biology, because the union of sperm 
and mature oocyte at fertilization triggers the recombination of paternal and maternal genetic 
information to form the diploid genome of a new and unique individual [7]. Understanding the 
stages of pre-implantation development and the underlying regulatory cellular and molecular 
mechanisms offers essential implications for assisted reproductive technology (ART).
In preparation for implantation and pregnancy, uterine endometrium transforms into a 
differentiated maternal tissue “decidua” through a remarkable event known as decidualization 
[28, 29] in response to estrogen and progesterone. The decidua is characterized by vascular 
remodelling, differentiation of stromal cells into large rounded decidual cells, angiogenesis and 
secretory transformation of uterine glands [28, 30].
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Human pre-implantation development
Pre-implantation embryos are morphologically similar in humans and mice, although the 
timing is quite different from each other (Figure 2) [31]. 
In humans, simultaneously with sperm-oocyte fusion, the second meiotic division 
of the oocyte is complete and the second polar body is extruded [26]. In the one-cell zygote, 
paternal and maternal haploid pronuclei move towards each other and they both undergo DNA 
replication before entering the first mitotic division [32] to produce a 2-cell embryo within one 
day after fertilization. Afterwards, the embryo undergoes a series of mitotic cell divisions (known 
as cleavage divisions) and produces sequentially smaller embryonic cells (called blastomeres). 
As cleavage divisions continue, the embryo “compacts” to form a solid ball of cells 
(morula) by day 4 of development (Figure 2). Products of several genes are involved in this 
compaction and the following cavitation process, including the sodium-potassium ATPase 
transport system and tight junction proteins [33]. The sodium/potassium ATPases on the cell 
membrane transport sodium from outside environment into the morula, followed by water flow 
into the embryo and formation of blastocoelic fluid. When a large cavity (blastocoel) is formed, 
the embryonic cells form a compact mass (called the inner cell mass or ICM) at one side of this 
cavity and a thin outer shell of epithelium (called trophectoderm or TE) [34]. Now the embryo 
is referred to as a blastocyst. In the blastocyst, TE cells adjacent to the ICM are polar TE, whereas 
the cells surrounding the blastocoel are mural TE [35]. 
By day 6 in humans, the developing blastocyst “hatches” from the protective zona 
pellucida [36], an acellular membrane that has protected the embryo as it has moved from the 
in humans and mice. 
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oviduct where cleavage takes place, into the uterus. The blastocyst is then ready to attach to the 
endometrial lining of the uterus. At around 6.5 days, the polar TE cells undergo syncytial fusion 
of mononucleated cells and produce the first syncytiotrophoblast, which is able to invade the 
uterine lining [37]. Implantation is only facilitated during a limited reception-ready phase (the 
“implantation window”), on days 7-10 of development in humans [38]. This restricted period 
is regulated by appropriate levels of ovarian estrogen and progesterone, which synchronize the 
timing of embryo development with uterine receptivity [39]. The complex but highly organized 
implantation process can be classified into three phases [40]: (1) apposition - close apposition of 
the blastocyst to the uterine lining; (2) adhesion - attachment of the blastocyst to endometrial 
surface epithelium; and (3) penetration - invasion of the embryo through the epithelial surface 
and into the endometrial stroma. Successful implantation, a crucial step in the establishment and 
development of normal pregnancy, depends on the interaction between receptive decidua and a 
good-quality blastocyst at the right time [41]. 
Mouse pre-implantation development
While this pre-implantation period lasts approximately one week in humans, mouse 
embryos undergo the same events in 4.5 days (Figure 2) [31]. Embryonic cells start to compact 
and differentiate at the morula stage around E2.5. By E3.5, with lineage segregation and the 
formation of cavitation, a blastocyst is formed. Between E3.5 and E4.5, the ICM further 
differentiates and segregates into primitive endoderm (PE) and the pluripotent epiblast (EPI). 
These pre-implantation cell fate decisions are concisely regulated by cell signaling and subsequent 
lineage-specific transcription factors [42, 43]. At E4.5, the blastocyst with three segregated cell 
lineages (TE, EPI and PE) hatches out of the zona pellucida and initiates implantation [42]. 
POST-IMPLANTATION DEVELOPMENT IN HUMANS AND MICE
Human post-implantation development
Following human implantation at day 7, the invasive syncytiotrophoblast, derived 
from polar TE, penetrates the uterine surface epithelium and thus draws the blastocyst deeper 
into the uterine wall [44]. The bilaminar embryonic disc comprises the EPI and the PE layers, 
both derived from ICM (Figure 2). By day 8, the amniotic cavity has appeared separating EPI 
from amnion while the syncytiotrophoblast grows and expands continuously. By day 9, the 
embryo becomes fully embedded within the uterine lining. The amniotic cavity expands, and 
trophoblastic lacunae appear in the syncytiotrophoblast which covers the embryo completely. 
On days 10-11, PE-derived primary yolk sac appears [45]. On days 11-13, the PE cells 
proliferate to produce the definitive (secondary) yolk sac whereas the primary yolk sac breaks 
up. An extraembryonic space, the chorionic cavity, is established. Its outer boundary, referred to 
as the chorion, is composed of trophoblasts and the underlying extraembryonic mesoderm [46]. 
During gastrulation on days 14-16, ingressing EPI cells converge at the midline and ingress at 
the primitive streak, replacing primitive endoderm to produce definitive endoderm [47]. Some 
EPI cells differentiate into embryonic mesoderm lying between the EPI layer and the definitive 
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endoderm layer. Cell movements in gastrulation transform the human embryo into a multi-
layered organism with three primary germ layers (ectoderm, definitive endoderm and embryonic 
mesoderm) (Figure 2) [48].
Mouse post-implantation development
Being quite distinct from human post-implantation embryo structures (Figure 2) [48], 
cells of the mouse blastocyst proliferate rapidly and transform the embryo into an egg cylinder 
within 24 hours after implantation [42]. Mural TE differentiates into primary trophoblastic 
giant cells [49], whereas polar TE subsequently differentiates into the ectoplacental cone (EPC) 
and the extraembryonic ectoderm (ExE) [50]. As the egg cylinder elongates, a luminal space is 
established within the EPI through polarization and hollowing, thereby transforming the EPI 
into a cup-shaped polarized epithelium [51]. The same process of polarization and hollowing 
also occurs in the ExE, the lumen eventually fusing to form the pro-amniotic cavity during 
E5.5–E5.75. The PE differentiates into parietal endoderm covering inner surface of mural 
trophectoderm and visceral endoderm cells covering the elongating egg cylinder (Figure 2) [42]. 
In the E6.5 mouse embryo, the primitive streak is formed in the posterior region of the EPI, 
which indicates the initiation of gastrulation [52]. Epiblast cells proliferate to cells that pass 
through the primitive streak, thereby giving rise to the mesoderm and the definitive endoderm 
which replaces the visceral endoderm [53]. Those EPI cells not moving through the primitive 
streak become the ectoderm. Together, these are the three primary germ layers (embryonic 
ectoderm, embryonic mesoderm and definitive endoderm) of the mouse embryo (Figure 2) [54]. 
A set of signaling pathways, including the WNT, BMP, Nodal and FGF pathways have been 
shown to be involved in this gastrulation process largely through gene deletion studies [55, 56]. 
At E7.25, PGCs arise from the epiblast, at the base of the mesodermal allantois [10]. 
EARLY PLACENTATION IN HUMANS AND MICE
During human and mouse implantation, decidua has three portions renamed by 
their relationship to the implantation site [28, 57]: (1) Decidua basalis, which underlies 
the implantation site; (2) Decidua capsularis, which lies between the uterine lumen and the 
implantation site; (3) Decidua parietalis, which is the rest decidua. The decidua basalis forms the 
basal plate which is the maternal part of the placenta.
Human early placentation
In the first week of development, the human embryo obtains nutrients by simple 
diffusion [58]. As the blastocyst attaches to the uterine epithelium, the formation of the placenta 
begins [59]. From day 8, TE-derived invasive trophoblasts penetrate the decidual stroma and the 
trophoblastic lacunae within the syncytiotrophoblast start to contact with maternal capillaries 
[31, 37]. During days 11-13, the cytotrophoblasts, acting as stem cells, proliferate and bud 
into the overlying syncytiotrophoblasts. The cytotrophoblast cells, together with an outer layer 
of syncytiotrophoblasts, grow out into the lacunae, thus forming primary villi [60]. Thereafter, 
the extraembryonic mesoderm cells proliferate and penetrate into the primary villi, forming 
13
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secondary villi. By week 3, within the villous mesoderm core, hematopoietic progenitor cells 
develop and give rise to placental blood cells [61]. The villi containing the first placental blood 
vessels are referred to as tertiary villi [62]. 
Due to the rapid placental growth during early pregnancy as well as apoptosis in the 
syncytiotrophoblast layer [63], the villous cytotrophoblast cells continuously proliferate, 
differentiate and fuse into the outer syncytiotrophoblasts [64]. This differentiation and fusion 
process involves syncytin genes encoding proteins which can induce cell-cell fusion [65, 66]. 
In the distal part of the anchoring villi, cytotrophoblasts proliferate and differentiate into cell 
columns, where trophoblast cells acquire an invasive phenotype during differentiation. These 
invading trophoblasts, known as extravillous trophoblasts (EVTs), detach from the cell columns 
and start to migrate into the decidua and even the myometrium [67, 68]. This trophoblast 
differentiation process is tightly regulated by oxygen tension and proper interplay of transcription 
factors, hormones, growth factors and other signaling molecules [69]. Four subsets of EVTs have 
been identified: (1) Interstitial EVTs, which invade the decidual stroma and even into the inner 
third of the myometrium; (2) Endovascular EVTs, which can migrate into maternal remodelled 
spiral arteries in a retrograde fashion [70] and into maternal uterine veins [71]; (3) Intramural 
EVTs, which are present in vascular wall of the remodeled spiral arteries [72]; (4) “Epithelial” 
EVTs, which line the basal plate together with maternal endothelial cells [73].
EVTs are observed to “block” or “plug” the opening of spiral arteries into the intervillous 
space at W8-W12 [74]. Because of these “blocks” or “plugs”, the maternal circulation to the 
placenta is restricted, thereby creating an hypoxic placental environment which is vital for 
regulating trophoblast cells differentiation during early pregnancy [75]. In addition, EVTs have 
been shown to be involved in the process of arterial remodelling together with macrophages 
and uterine natural killer (uNK) cells [76]. Initially, unremodelled decidual arteries consist of 
an intact endothelium and several well-organized smooth muscle cell (SMC) layers. Before 
EVT invasion of the spiral arteries, leukocytes infiltrate the vascular wall, synchronized with 
disorganization of the SMC layers and loss of endothelial cells. Under subsequent remodelling by 
interstitial and endovascular EVTs, decidual arteries lose endothelium and SMC layers entirely 
[77]. Remodelled decidual arteries lack maternal vasomotor control [78] and therefore become 
low-resistance, heavily dilated vessels that provide increased blood flow towards the placenta 
to meet the requirements of the growing fetus. At about W12, the open connection between 
maternal circulation and intervillous space is completely established [78, 79]. In this process, 
proper EVT invasion in decidual vasculature regulates oxygen tension for placental development 
[75] which is vital for successful pregnancy [80, 81]. On the contrary, insufficient EVTs invasion 
in maternal decidua is reported to result in inadequate blood perfusion of the placenta and 
subsequent pregnancy complications including preeclampsia and intrauterine growth restriction 
[82, 83]. Thus, characterizing the invasion of fetal EVTs in maternal decidua basalis in early 
pregnancy will help to identify the underlying mechanism and reveal potential therapeutic 
strategies for some pregnancy complications. 
14
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Mouse early placentation
In mice, the mesoderm-derived allantois contacts with chorion at E8.5 [84]. This 
event, called “chorioallantoic fusion”, starts the formation of early placenta. Thereafter, fetal 
components of the placental vascular network undergo extensive branching and grow into the 
folds of the chorion [84]. At the same time, chorionic trophoblast cells, in direct apposition with 
endothelium of the fetal vessels, differentiate into multiple layers of trophoblast cells: two layers 
of syncytiotrophoblast cells and another layer of mononuclear trophoblast cells [85]. Maternal 
blood flows through the small spaces among trophoblast cells at around E10.5, resulting in a 
functional placenta exchanging maternal and fetal blood [86]. By E14.5, the placenta finally 
develops into the definitive placenta [87].  
Mouse placentation shows many differences from humans [88]. Crucially, in contrast 
to human extensive trophoblast invasion into decidua and decidual vessels, mouse trophoblast 
invasion is very shallow [89]. Therefore, transformation of mouse uterine arteries is dependent 
on maternal (uNK) cells rather than fetal trophoblasts [90].
LATE PLACENTATION IN HUMANS AND MICE
The placenta is the first fully-formed organ in mammals. It supports the directional 
and selective transport of nutrients, gases and waste between maternal and fetal circulations 
during intrauterine development [91]. It maintains pregnancy and supports fetal development 
and growth. Therefore, placental dysfunction may lead to pregnancy complications causing risk 
to mother and fetus [92]. Mouse and human placentae are haemochorial, meaning that the 
maternal blood directly contacts fetal trophoblast cells [93, 94]. The other two types of placenta, 
epitheliochorial placenta (as observed in horse, cow and pig) and endotheliochorial placenta (as 
described in cat and dog) have a barrier between fetal villi and maternal blood [94, 95]. 
Human late placentation
In humans, the chorionic surface is entirely covered by chorionic villi during the first 
8 weeks. As the gestational sac enlarges, chorionic villi on the decidua capsularis undergoes 
progressive regression into a smooth surface called “chorion laeve” [96, 97]. The chorion laeve 
fuses with decidua parietalis by the end of the third month. Chorionic villi on the decidua basalis 
become larger and more extensively branched.
By the end of the fourth month of pregnancy, the human placenta has attained its 
definitive structure and function (referred to as “definitive placenta”), consisting of fetal terminal 
chorionic villi and maternal decidua (Figure 3A) [98, 99]. The villi are composed of an inner 
EPI-derived mesenchymal core and two layers of TE-derived trophoblast epithelium (a layer 
of mononuclear cytotrophoblast cells and a layer of multinucleated syncytiotrophoblast cells) 
[37]. The chorionic villi either attach to the decidua basalis as anchoring villi or float within the 
intervillous space as floating villi [69]. 
The high-flow low-resistance maternal remodelled arteries accommodate massively 
15
General introduction | 
1
increased maternal blood perfusion into the intervillous space [78]. The relatively high 
arterial pressure allows exchange between maternal and fetal blood to take place. This must 
cross four layers of tissue (the placental barrier): two villous trophoblast layers (one layer of 
syncytiotrophoblasts and one layer of cytotrophoblasts), the connective tissue (extraembryonic 
mesoderm) in the core of villi and the fetal capillary endothelium [100]. After exchange of fetal 
and maternal blood at the external microvillous surface of chorionic villi, the single umbilical 
vein carries oxygenated blood and nutrient to the fetus. Then the two umbilical arteries transport 
deoxygenated fetal blood and waste product back to the placenta [101]. In-flowing maternal 
arterial blood pushes venous blood back to decidual veins through venous orifices in the basal 
plate. Thus, the maternal blood traverses the intervillous space of the placenta freely without 
preformed channels. 
Mouse late placentation
Since E11.5, mouse definitive chorioallantoic placenta is established, composed of 
distinct structural layers [102]: maternal decidua with spiral arteries perfusion, an outer layer of 
trophoblast giant cells (TGCs) interfacing with the maternal decidua, followed by the junctional 
zone [glycogen cells (GCs) and spongiotrophoblasts], the labyrinth (trophoblast cells and 
extraembryonic mesoderm endothelial cells) and finally the chorionic plate facing the embryo 
[84, 103, 104] (Figure 3B). The GCs, which have high glycogen content and are sensitive to 
glucagon signaling, may be serving as a potential source of energy [105].
Maternal spiral arteries traverse the decidua basalis and converge to form centrally located 
arterial “canals” which carry maternal blood to the base of labyrinth [89] (Figure 3B). In the 
labyrinth, fetal and maternal blood exchanges, with the well-organized cell layers (a layer of 
mononuclear trophoblasts, a bilayer of syncytiotrophoblasts and an endothelial cell layer of 
the fetal vasculature) serving as the barrier between maternal-fetal exchange [101]. Afterwards, 
venous deoxygenated blood drains from the labyrinth through venous channels in the junctional 
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EPIGENETIC REGULATION IN GERM CELLS, PERI-IMPLANTATION AND 
PLACENTAL DEVELOPMENT
Epigenetic regulation is crucial for various biological processes. Two epigenetic regulation 
processes established in early development [106], X chromosome inactivation (XCI) and genomic 
imprinting, are essential for dosage control of X-linked genes and parent-of-origin-specific genes 
in certain cells at certain stages.
X chromosome inactivation
In mammals, XCI is the mechanism to achieve dosage compensation of X-genes between 
females and males, in which one of the two X chromosomes becomes inactivated (Xi) in female 
somatic cells [106, 107]. XCI is regulated by X inactivation centre (Xic) [108, 109], which 
includes the non-coding locus XIST and its antisense transcript TSIX as a repressor [110]. 
XIST RNA coats the future inactive X chromosome, thus trigging the silencing of the whole X 
chromosome. This is followed by DNA methylation at CpG-rich promoters, histone H3 lysine 
27 trimethylation (H3K27me3) and H4 hypoacetylation [106, 111]. Individuals, even with 
abnormal numbers of X chromosomes, silence all but one of the X chromosomes [112]. For 
example, Turner syndrome patients (45,XO) harboring a single X chromosome [113] show no 
inactivation of this unique X chromosome. Klinefelter syndrome patients (47, XXY) display one 
active and one inactive X chromosomes [114]. Additionally, a fraction of X-genes are revealed 
to escape X inactivation on the Xi and are known as “escapees”. A higher percentage of escapees 
along chromosome X are reported in humans (around 15%) than in mice (about 3%) [115, 116]. 
Many of the escapees are located in the pseudoautosomal regions [117], where genes are present 
on both X and Y chromosomes.
XCI has been investigated by several approaches including XIST RNA-FISH [118], 
H3K27 trimethylation [119], human androgen receptor gene assay (HUMARA) [120], retinitis 
pigmentosa 2 (RP2)-based assay [121] and allele-specific expression analysis of the informative 
single-nucleotide polymorphisms (SNPs) enabling parental origin to be assigned [122-124]. 
The dynamic XCI status during early development has been more extensively studied 
in mice than in humans, because of the availability of genetic substrains of mice [125-127]. 
After fertilization, X inactivation is initiated during pre-implantation development of mouse 
female embryos, closely related to the early lineage segregation [125]. The first XCI wave occurs 
at the two- to four-cell stage and results in the imprinted inactivation of Xp in all cells of the 
embryo (Figure 2). At the blastocyst stage, the Xp remains silent in the TE and PE [103, 126, 
127] while the Xp becomes reactivated in the EPI at E3.5. Shortly thereafter, during the second 
XCI wave, either the Xm or the Xp is silenced in a random fashion, resulting in random XCI 
in epiblast cells (Figure 2) [128]. This is followed by reactivation of the silent X, in preparation 
for the equal segregation during meiosis, in female PGCs between E8.5 and E12.5, but not 
in the female somatic cells [119]. During placentation, mouse TE-derived cells maintain 
imprinted XCI. Therefore, TE-derived cells in the placenta contain an obligatorily silenced 
17
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Xp in females, including the TGCs, the spongiotrophoblasts and GCs in the outer zone and 
the syncytiotrophoblasts, mononuclear trophoblasts in the labyrinth zone [102]. By contrast, 
EPI-derived cells in the placenta, including the chorionic plate of the placenta and the fetal 
endothelial cells in the labyrinth zone, show random XCI. 
The process of XCI in humans is less well-known than in mice. The inactivated X 
chromosomes in human PGCs are already reactivated at W4 [122]. During pre-implantation 
development at E3-E7, X-linked genes are thought to maintain biallelic expression in all lineages 
[118, 129]. Previous research regarding XCI in human placenta has resulted in conflicting views, 
supporting random [124, 130-133], non-random [134] and preferential paternal XCI [135-
139]. These conflicting results may be due to high heterogeneity, clonal growth and a mixture of 
TE-derived and EPI-derived cells in placenta.  
Genomic imprinting
In mammals, normally both maternal and paternal alleles of genes are expressed. However, 
genomic imprinting affects a subset of genes (known as imprinted genes) in both male and 
female offsprings, resulting in monoallelic expression of either maternal or paternal allele [106]. 
Most imprinted genes are located in clusters [140] that are regulated by transcription of a non-
coding RNA. Imprinted genes play an essential role in embryonic and extraembryonic growth 
and development in mammals [141, 142].
IGF2/H19 locus, which is located on human chromosome 11 and on mouse chromosome 
7, is one well-studied imprinted gene cluster [143, 144]. The location of its imprinting control 
region (ICR) is between protein-coding IGF2 gene and noncoding H19 gene [145]. The 
ICR on the maternal chromosome is bound by the insulator protein CTCF, and therefore is 
unmethylated. This allows activation of the H19 promoter and inactivates of the IGF2 promoter. 
As a result, the maternal chromosome has transcription of H19 but not IGF2. In contrast, the 
ICR is methylated on the paternal chromosome and IGF2 is transcribed [144].
A couple of techniques have been used to detect imprinting patterns [146], including 
DNA methylation at ICRs and allele-specific expression analysis of informative SNPs. Sperms 
and mature oocytes carry imprinted chromosomes. After fertilization, the imprint is maintained 
in each cell division during peri-implantation and placental development [147]. Genome-wide 
epigenetic reprogramming in human and mouse PGCs results in erasure of parental imprints 
before sex determination [147]. Upon sex determination, male and female germ cells acquire 
paternal and maternal imprints respectively on the chromosomes. 
18
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AIMS AND OUTLINE OF THIS THESIS
Pre-implantation and placental development in humans and mice has been investigated 
over several centuries. Although much is known about early development in mice, how 
differentiation and implantation are regulated at the molecular level in humans is limited. Since 
incorrect development and implantation is thought to be a cause of pregnancy failure and risk, 
the work in this thesis aimed to fill some of these gaps and specifically address the following 
aspects related to pre-implantation and placental development in humans and mice. 
The main question of Chapter 2 is what is the development of human (extra)gonadal 
germ cells between first and second trimesters regarding expression of germ cell markers and 
meiosis markers. Are there ectopic germ cells and do they enter meiosis in synchrony with the 
gonadal germ cells? 
The main aim of Chapter 3 is to investigate the status of XCI in human pre-implantation 
embryos. Do TE-derived cells show different XCI pattern from ICM-derived cells at E5-E7? If 
there is X inactivation, whether the XCI pattern is imprinted or random?
The focus of Chapter 4 is on the invasion of decidual vasculature by human extravillous 
trophoblast cells from W5.5 till the end of first trimester. Do the EVTs invade arteries, veins and 
lymphatics? When does the invasion occur? 
In Chapter 5, the investigation is extended towards the spatial pattern of methylation of 
the IGF2/H19 imprinting control region in multiple sites of collection in human first-trimester 
placental villi. Do the multiple sites of placental villi show the same imprinting pattern? Is 
the imprinting pattern of IGF2/H19 in human first-trimester placental villi the same as in the 
embryo?
The aim of Chapter 6 is to compare the consequences of Turner syndrome harboring 
either a single paternally inherited (Xp) or maternally inherited (Xm) chromosome in mouse 
E18.5 placenta, in order to study whether the transcriptional level of Xp is equal to Xm.
Finally in Chapter 7, we combine and further discuss the findings obtained in chapters 
2-6. Future perspectives are also proposed.
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ABSTRACT
Human germ cells originate in an extragonadal location and have to migrate to colonize 
the gonadal primordia around 7 weeks of gestation, W7 (or 5 weeks post conception). Many 
germ cells are lost along the way and should enter apoptosis, but some escape and can give rise 
to extragonadal germ cells tumors. Due to the common somatic origin of gonads and adrenal 
cortex, we investigated whether ectopic germ cells were present in the human adrenals. Germ 
cells expressing DDX4 and/or POU5F1 were present in male and female human adrenals in 
the first and second trimester. However, in contrast to what has been described in mice, where 
‘adrenal’ and ‘ovarian’ germ cells seem to enter meiosis in synchrony, we were unable to observe 
meiotic entry in human ‘adrenal’ germ cells until W22. By contrast, ‘ovarian’ germ cells at W22 
showed a pronounced asynchronous meiotic entry. Interestingly, we observed that immature 
POU5F1+ germ cells in both first and second trimester ovaries still expressed the neural crest-
marker TUBB3, reminiscent of their migratory phase. Our findings highlight species-specific 
differences in early gametogenesis between mice and humans. We report the presence of a 
population of ectopic germ cells in the human adrenals during development.
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INTRODUCTION
In humans, primordial germ cells (PGCs) originate outside the gonadal primordia, in 
the posterior part of the yolk sac, close to the allantois and hindgut wall and undergo a phase 
of proliferation and migration towards the gonadal ridge [1, 2]. Normally, these PGCs reach 
gonadal primordia around week 7 of gestation (W7, or week 5 post conception) to become 
enclosed in either seminiferous tubules or ovarian cords, respectively in male and female embryos 
[3]. 
However, some PGCs in humans may stop migrating along the way to the gonads [4] or 
become lodged in extragonadal organs. The most obvious ectopic organ to lodge PGCs would 
be the adrenal glands (or adrenals). This is because the somatic gonad and adrenal cortex, both 
steroid-producing organs, have a common somatic origin and both organs are colonized by 
migratory neural crest cells [2, 5, 6]. In mice and bovine, ectopic germ cells have been described 
in the adrenal glands [7-9]. Ectopic germ cells present along the migratory pathway are most of 
the times eliminated by apoptosis [10, 11]; however, when lodged in the adrenal glands some 
of these ectopic germ cells survive and are able to undergo meiosis to become oocytes in both 
females and males [7, 9]. This suggests that the adrenal glands may provide a microenvironment 
that induces (or allows) germ cells to undergo a female sex differentiation pathway. Interestingly, 
these adrenal ‘oocytes’ seem to develop synchronous with gonadal ‘oocytes’ regarding growth, 
meiotic entry and they even develop a zona pellucida [9], in agreement with the current view of a 
default female pathway in the urogenital region, initiated by exposure to retinoic acid (RA) and 
blocked in the male gonad by local degradation of RA or related metabolites [12-14].
In different animal models, PGCs follow different ‘routes’ to reach the gonads, including 
the gut and abdominal mesentery in mice [15] or the vasculature in chicken [16]. Interestingly, 
it has been suggested that in humans, PGCs may migrate along the peripheral nervous system 
[2, 4]. Sympathetic nerve fibers were also found in the adrenal glands and indeed human ectopic 
PGCs could enter the adrenal glands via these fibers [4].
Here, we have investigated the presence of ectopic human germ cells in the adrenals 
during human development (from W8.4 until W22) and investigated how these ectopic germ 
cells developed by comparing the dynamics of expression of early, late and meiotic germ cell 
markers between the adrenal and the gonadal germ cells. ‘Adrenal’ germ cells seem to upregulate 
the late marker DDX4, but we were unable to observe ‘adrenal’ germ cells entering meiosis until 
W22. However, we show that meiotic entry in human female gonads is an asynchronous process 
that is still taking place after W22. We discuss possible ways of how the human germ cells reach 
the adrenals and on the fate of those ‘adrenal’ germ cells. 
MATERIAL & METHODS
Animals and ethics statement
The mouse E15.5 female embryos (n=7) used in this study were part of a collaboration 
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with Dr A. McLaren (University of Cambridge, UK, who sadly passed away on 7 July 2007) 
and were obtained according to the UK Home Office guidelines. The embryos were fixed 
overnight in 4% paraformaldehyde (PFA, Merck, Darmstadt, Germany) and stored in 100% 
methanol at −20°C. After rehydration, the embryos were embedded in 4% low-melting agarose 
(Life Technologies, Eugene, OR, USA) in PBS and were sectioned (200 μm) with a Vibratome 
HM650V (Microm, Walldorf, Germany). The vibratome sections were boiled 20 min in 0.1 
M Tris-HCl, pH 8.5, followed by blocking overnight at 4°C with 0.5% bovine serum albumin 
(BSA, Life Technologies) diluted in Tris-buffered saline (TBST; 0.14 M NaCl, 2.5 mM KCl, 
25 mM Tris pH 7.4) with 0.1% Triton X-100. Then sections were incubated overnight at 4°C 
with primary antibodies: rabbit anti-DDX4 (1:1000, ab13840, Abcam, Cambridge, UK) and 
rabbit anti-SYCP3 (1:500, NB300-232, Novus Biologicals Littleton, CO, USA) diluted in 0.5% 
BSA in TBST. The sections were washed with TBST at 4°C, followed by overnight incubation 
at 4°C with secondary antibodies: Alexa Fluor 568 goat anti-rabbit IgG (1:500, A-11011, Life 
Technologies) in 0.5% BSA in TBST, washed with TBST at 4°C and mounted with Vectashield 
Hard Set Mounting medium with 4',6-diamidino-2-phenylindole (DAPI) (Vector Laboratories, 
Burlingame, CA, USA).
Ethical approval for use of human material
Human fetal gonads (n=8 females; n=6 males) and adrenal glands (n=12 females; n=11 
males) (S1 Table) were donated for research with informed consent from elective abortions 
without medical indication. The gestational age in weeks and days (for example W8.4 means 
8 weeks and 4 days) was determined prior to the procedure by obstetric ultrasonography. To 
obtain ‘weeks post conception’ one needs to subtract two weeks from the given ‘gestational 
age’, determined by the last menstrual period (LMP). Both collection and use of human fetal 
tissues was approved by the Medical Ethical Committee of the Leiden University Medical Center 
(P08.087).
Sex genotyping, histology and immunofluorescence
The sex genotyping of the human fetal tissues, processing for histology and 
immunofluorescence were performed essentially as previously described [3]. All 
immunofluorescence staining was performed using 0.01 M citric buffer pH 6.0 for antigen 
retrieval. The primary antibodies used were goat anti-DDX4 (1:1000, AF2030, R&D Systems, 
Minneapolis, MN, USA), rabbit anti-DDX4 (1:500, ab13840, Abcam, Cambridge, UK), goat 
anti-POU5F1 (1:100, sc-8628, Santa Cruz Biotechnology, CA, USA), rabbit anti-SYCP3 
(1:500, NB300-232, Novus Biologicals Littleton, CO, USA), mouse anti-H2AFX (Ser139) 
(1:500, 05-636, Millipore Temecula, CA, USA) and mouse anti-TUBB3 (1:500, ab78078, 
Abcam, Cambridge, UK). The secondary antibodies used were Alexa Fluor 594 donkey anti-goat 
(1:500, A11058, Life Technologies), Alexa Fluor 488 donkey anti-rabbit (1:500, A21206, Life 
Technologies), Alexa Fluor 594 donkey anti-mouse (1:500, A-21203, Life Technologies), Alexa 
Fluor 647 donkey anti-rabbit (1:500, A-31573, Life Technologies), Alexa Fluor 488 donkey 
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anti-goat (1:500, A-11055, Life Technologies), Alexa Fluor 555 donkey anti-rabbit (1:500, 
A-31572, Life Technologies) and Alexa Fluor 488 donkey anti-mouse (1:500, A21202 Life 
Technologies). Negative controls were performed by omitting the primary antibodies. TUNEL 
(terminal deoxynucleotidyl transferase dUTP nick end labeling) assay was performed using In 
Situ Cell Death Detection Kit (Roche Diagnostics, Mannheim, Germany). The sections were 
incubated at 37°C for 1 h. All slides were counterstained with a 1:1000 dilution of DAPI (Vector 
Laboratories, Peterborough, UK) in PBS for 1 min and mounted with ProLongGold antifade 
reagent (Life Technologies).
Imaging and quantification
After immunofluorescence, slides were analyzed and photographed on a Leica 
DMRA fluorescence microscope (Leica, Wetzlar, Germany) with the CoolSnap HQ2 camera 
(Photometrics, Tucson, USA) or on a Leica AF6000 fluorescence microscope equipped with a 
Hamamatsu EM-CCD C9100 digital Camera (Leica Microsystems, Wetzlar, Germany). The 
slides (consecutive for first trimester and every 5-10th for second trimester) were scanned on a 
Panoramic MIDI digital scanner (3DHISTECH Ltd., Budapest, Hungary) and analyzed with the 
software program ‘Panoramic viewer’ (3D HISTECH, Budapest, Hungary). Using this software, 
that allowed digital zooming and channel selection, we quantified the total number of germ cells 
per scanned section. Examples of POU5F1+DDX4−/low, POU5F1+DDX4+, DDX4+ germ 
cells are presented in Fig 4. To be considered a ‘germ cell’, POU5F1 was nuclear, DDX4 was 
cytoplasmic, DAPI (chromatin condensation) was adequate to the stage of development, both 
cell and nucleus had the typical germ cell shape and size; the immunostaining pattern was not 
observed in the negative controls.
Expression analysis 
From online available single cell RNA sequencing data of human gonadal cells of first 
and second trimester (n=328 cells including somatic and germ cells), the expression data in 
fragments per kilobase of transcript per million (FPKM) of all the female germ cells (n=93) was 
downloaded from the Gene Expression Omnibus (GEO) database (GEO: GSE63818) [17]. 
For this analysis all male germ cells (n=149) and gonadal somatic cells (n=86) were excluded. 
Genes involved in neural crest cell development, migration and differentiation were obtained 
based on the GO_BP annotation (GO:0014033, GO:0001755, GO:0014033) from http://
www.ensembl.org/biomart. The heatmap showing the log2(FPKM+1) was generated with the 
R package gplots.
RESULTS
Germ cells were present in several ectopic locations in female mice embryos
First, we investigated the presence of germ cells at ectopic locations in mice at embryonic 
day (E)15.5 when basically all female gonadal germ cells have entered meiosis [18]. Using 
immunofluorescence for the late germ cell marker DDX4 (or VASA) and the meiotic marker 
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SYCP3, we observed the presence of DDX4-positive and SYCP3-positive germ cells in the E15.5 
females analyzed (n=7) not only in the ovaries, but we also observed some germ cells in the 
mesonephros, sometimes in the abdominal mesentery, peri-aortic region, adrenal glands and a 
few in the proximity of the surface ectoderm, close to the external genital region and base of tail 
(Fig 1A-C).
Germ cells were present in human fetal male and female adrenals
Next, we investigated the presence of germ cells in human fetal adrenal glands in females 
and in males (S1 Table) by immunofluorescence for DDX4 and the early germ cell marker 
POU5F1 (or OCT4). We were able to detect single and double POU5F1/DDX4-positive germ 
cells, sometimes in small clusters, in all first trimester adrenal glands analyzed from W8.4-W13 
(Fig 2A-B and S1 Fig). We quantified consecutive sections of several adrenals (n=3 females and 
n=3 males) and the majority of the sections contained 1 to 10 germ cells (Table 1). Moreover, 
POU5F1/DDX4-positive germ cells were never detected in the kidneys, when those were present 
in the slides.
 To understand whether these ‘adrenal’ germ cells were entering meiosis, we used 
immunofluorescence for DDX4 and either (phosphorylated) H2AFX, a marker associated with 
DNA double-strand breaks both during meiosis entry, but also apoptosis [19-21] or SYCP3. 
Both in female and male first trimester adrenals, DDX4+ germ cells were never positive for 
Fig 1. Ectopic germ cells in mice female 
embryos at E15.5. 
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H2AFX (Fig 2C-D and S1 Fig) or SYCP3 (S2 Fig). However, many H2AFX+ cells were observed 
in the adrenals and could correspond to adrenal cells undergoing apoptosis. To further investigate 
the fate of DDX4+ cells in the adrenals, we also performed TUNEL assay (Fig 2E-F and S1 Fig), 
but were unable to observe ‘adrenal’ DDX4+ germ cells in apoptosis. We conclude that during 
first trimester, pre-meiotic germ cells are relatively abundant in the adrenals (Fig 2).
We proceeded analyzing both female and male second trimester adrenals ranging from 
W14-W22, where we encountered germ cells at the periphery of the adrenal (Fig 3A-B, Table 
1; S3 Fig), but we were unable to detect H2AFX+ germ cells (Fig 3C-D and S3 Fig) or SYCP3+ 
germ cells (S2 Fig). From the few germ cells encountered none were positive for TUNEL (Fig 
3E-F and S3 Fig). Our results in human are in contrast with results in mice showing that germ 
cells observed in the adrenals were able to survive and mature [7, 9].
Developmental dynamics of human germ cells in first and second trimester
As we were unable to observe meiotic entry in the human ‘adrenal’ germ cells until W22, 
we investigated the spatial dynamics of meiotic entry in human ovaries, when possible from 
the same individual from which we had analyzed the adrenals (S1 Table). We discriminated 
firstly between POU5F1+ and DDX4+ germ cells (Fig 4A) and, secondly, we immunostained 
consecutive sections for two independent meiotic markers, H2AFX and SYCP3 (Fig 4B).
As previously observed by us and others [3, 22], in first trimester ovaries most germ cells 
were POU5F1+ and expressed either low (or no) DDX4, consisting of a relatively homogeneous 
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population of germ cells (zone 1) (Fig 4A, Table 2; S4A Fig). During second trimester, we 
observed a shift towards DDX4+ germ cells interiorly (zone 2), whereas a pronounced peripheral 
layer of POU5F1+ cells remained (Fig 4A, Table 2; S4B Fig). At W21.5, the majority of germ 
cells in the ovary were DDX4+POU5F1− and localized interiorly. In addition, some of these 
DDX4+ cells were developing into primordial follicles (zone 3) (Fig 4A).
Germ cells in male gonads were also quantified and, as in females, a shift towards 
DDX4+POU5F1− germ cells was observed between the first and second trimesters (Fig 5A, 
Table 2; S5 Fig). Until W22, male germ cells expressed neither H2AFX nor SYCP3 (Fig 5B).
Asynchronous meiotic entry in human ovarian germ cells
In human ovaries, H2AFX was upregulated in many germ cells at W14 (Fig 4B). 
However, at W17, germ cells in zone 2 (where most DDX4+ germ cells were located) showed 
chromatin decondensation and interestingly either predominately H2AFX or SYCP3 filament-
like expression (Fig 4B, Fig 6A,Ai), suggestive of meiotic entry. By contrast, cells in the peripheral 
area (zone 1), where most POU5F1+ germ cells located remained negative for both meiotic 
markers (Fig 4B). Later, at W21.5, as zone 1 becomes thinner, more peripheral germ cells started 
showing chromatin decondensation and a salt-and-pepper pattern expression of H2AFX, SYCP3 
or both (Fig 4B; Fig 6B,Bi,C,Ci). In primary follicles in zone 3, the oocytes expressed neither 
H2AFX nor SYCP3 (Fig 6D,Di). However, it is clear that many germ cells in zone 1, most 
Fig 5. Dynamic expression of germ cell 
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probably POU5F1+DDX4−/low germ cells, had not entered meiosis by W21.5. Comparing 
our data with that reported for spread human spermatocytes double-stained for H2AFX and 
SYCP3 [23], we conclude that H2AFX+SYCP3−/low germ cells were in (pre-)leptotene, germ 
cells containing patches of H2AFX and SYCP3 were in zygotene; SYCP3+H2AFX− germ cells 
were in pachytene and the SYCP3−H2AFX− oocytes in primordial follicles, as the synaptonemal 
complexes dissolve, have reached diplotene.
It has been reported that human germ cells show marked asynchrony regarding meiotic 
phases during fetal ovarian development [24] and this is in agreement with our data. However, 
even though we observed a maturation wave from peripheral POU5F1+ germ cells to the more 
inner-located primordial follicles, we have no evidence to support the idea that the different 
prophase meiotic phases occur in a wave-like manner in the ovary.
Association between human germ cells and neural crest derivatives
To further understand the relationship between the ‘ovarian’ and ‘adrenal’ germ cells, we 
studied the presence of neural crest derivatives in both adrenals and ovaries between W9 and 
W22. Neural crest derivatives, marked by class III beta-tubulin (TUBB3), have been described 
to guide human PGCs towards the gonadal primordia [2, 4] and perhaps inadvertently to other 
organs, including the adrenals.
Surprisingly, we observed that most POU5F1+ germ cells in the ovaries from both first 
and second trimester were strongly positive for TUBB3 (Fig 7A-B). However, most DDX4+ 
germ cells in the second trimester were TUBB3− (Fig 7B). This was interesting because it 
suggested that early human germ cells could have a ‘neural crest’ related expression signature, 
reminiscent of their migratory phase. We are aware that TUBB3 is not an exclusive marker for 
migratory neural crest cells, but is a general marker for the neural lineage [25]; and it is possible 
that this and many other genes are expressed in germ cells as a consequence of the global DNA 
(A
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demethylation that PGCs undergo during migration [17].
We investigated this further by interrogating an online available single cell transcriptomics 
dataset of human female germ cells from first and second trimester [17]. Using early (POU5F1, 
NANOG, KIT) and late markers (DAZL, DDX4, SYCP3, SYCP2, SYCP1, HORMAD2) to 
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differentiate between early and late human female germ cells, we confirmed that the majority of 
early POU5F1+DDX4−/low germ cells (in zone 1) expressed TUBB3, whereas late DDX4+ germ 
cells (zone 2) did not. However, except for TUBB3 and perhaps ACVR1 (or ALK2), a receptor 
associated with germ cell development in mice [26], we did not find a clear association between 
early germ cells and markers of neural crest cell development, migration or differentiation (Fig 
7C). Late DDX4+ germ cells were enriched for neural crest markers such as RDH10, ALDH1A2, 
PAX6, PHACTR4, SMAD4 and LRP6 (Fig 7C). 
We were able to detect many TUBB3+ nerve bundles penetrating the first trimester 
adrenals (to form the adrenal medulla) and there we could also observe POU5F1+ and/or 
DDX4+ germ cells (Fig 7D), in agreement with others [4]. The few peripheral DDX4+ cells 
encountered in the second trimester expressed no (or low) levels of TUBB3 (Fig 7E), as in the 
ovary.
DISCUSSION
How do the human germ cells end up in the adrenals?
We observed that ‘ovarian’ and ‘adrenal’ POU5F1+ germ cells expressed TUBB3. As 
these germ cells are still phenotypically immature, expression of TUBB3 is a reminiscence of the 
migratory phase of germ cells and a common characteristic with neural crest derivatives [2, 4]. 
Whether germ cells only share this characteristic with neural crest cell derivatives or effectively 
depend on structural support provided by neural crest derivatives to colonize the gonadal ridge 
(or the adrenals) remains to be elucidated. We could envisage that neural crest cells and PGCs 
could use (partly) common migratory routes, share common markers, or respond to similar 
chemo-attractant cues to colonize both the adrenal and genital primordia.
An alternative explanation to the presence of germ cells in the adrenals is the common 
origin of the human gonadal primordia and adrenal primordia, both initially expressing high 
levels of DAX1 (also known as NR0B1) and SF1 (also known as NR5A1) [6, 27, 28]. The 
colonization by the PGCs, at least in rats, is shown to occur before the physical separation of 
gonadal and adrenal primordia [29]. It is feasible that in humans this also occurs and that some 
germ cells reach the adrenal primordia and remain there after the two organs separate. 
Do human ‘adrenal’ germ cells enter meiosis synchronously with ‘ovarian’ 
germ cells?
In mice, the meiotic wave (described from anterior to posterior) in females is of relatively 
short duration (from E11.5 to E12.5) and gametogenesis during mice embryonic development 
is further a rather synchronous process [30]. By contrast, the process of gametogenesis from 
PGCs to primordial follicle in female human germ cells is strongly asynchronous and clearly 
spatially regulated [3, 22]. Here, we show that in humans the time window for the start of 
meiosis in females is less defined than in mouse and we did not observe robust meiotic entry (by 
SYCP3) at least until W17 in ovaries. However, even at W21.5 in the female gonads there was 
still a large population of germ cells that had not entered meiosis, particularly in the periphery 
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of the ovary. It would be interesting to investigate the fate of these peripheral POU5F1+ germ 
cells at later developmental stages. They may perhaps still enter meiosis or alternatively they may 
have missed the time window to do so and enter apoptosis. In any case, due to the asynchrony 
of meiotic entry it is difficult to predict when the expression of the meiotic markers should be 
expected to occur in the ‘adrenal’ germ cells in humans and we cannot exclude the possibility that 
‘adrenal’ germ cells enter meiosis after W22.
What happens to human ‘adrenal’ germ cells?
Ectopic human KIT+ and POU5F1+ germ cells have been described in the abdomen 
from W4 to W16 in the developing peripheral nervous system [2, 4]. Here, we show that ectopic 
germ cells at E15.5 in mice seem to be present in the adrenals, but also at other locations 
on their migratory path. In humans, although the number of adrenals analyzed was limited, 
‘adrenal’ germ cells seemed to be able to downregulate POU5F1 and upregulate DDX4, as in 
the ovary, but were unable to enter meiosis at least until W21.5. The ‘adrenal’ POU5F1 and/
or DDX4 germ cells were not apoptotic (TUNEL-positive). It remains unclear whether during 
further development, those germ cells remain in the adrenal or lose their germ cell identity by 
downregulating POU5F1 and DDX4.
Ectopic germ cells are thought to give rise to extragonadal germ cells tumors that occur in 
particular in midline structures [31, 32], if they fail to be eliminated by apoptosis, but develop 
instead malignant characteristics. Interestingly, genome-wide association studies (GWAS) 
have identified single-nucleotide polymorphisms (SNPs) in DDX4 as highly associated with 
neuroblastoma tumors [33]. Moreover, the origin of adrenal neuroblastoma tumors that occur 
mainly in children remains elusive, but has been associated with TUBB3-positive neural crest 
derivatives [34]. Because POU5F1+ germ cells both in ovaries and adrenals seem to express 
TUBB3 as well, it may be important to investigate the expression of additional markers to 
exclude a potential link between neuroblastoma and ‘adrenal’ germ cells.
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 Table 1. Quantification of germ cells in human adrenals 
ID sex age sections  POU5F1+DDX4-/low POU5F1+DDX4+ DDX4+   total 
    (weeks.days) (n) nr germ cells % nr germ cells % nr germ cells % nr germ cells 
AQ1 female W8.6 10 56 74.7 18 24.0 1 1.3 75 
AY1 female W9.6 10 23 46.0 8 16.0 19 38.0 50 
DR3 female W13 9 1 2.6 12 31.6 25 65.8 38 
DD2 female W16 84 0 0.0 0 0.0 2 100.0 2 
BQ1 female W17.4 49 0 0.0 0 0.0 2 100.0 2 
CC2 female W18 73 0 0.0 0 0.0 14 100.0 14 
BM2 female W20 146 1 6.7 0 0.0 14 93.3 15 
CD1 female W20.5 69 0 0.0 10 13.0 67 87.0 77 
AV1 male W8.4 10 6 15.8 32 84.2 0 0.0 38 
BG2 male W10 10 22 23.7 51 54.8 20 21.5 93 
AT1 male W12 8 1 10.0 4 40.0 5 50.0 10 
AZ1 male W15.4 35 0 0.0 0 0.0 0 0.0 0 
CV2 male W16.5 91 0 0.0 0 0.0 6 100.0 6 
CQ1 male W17 129 0 0.0 1 25.0 3 75.0 4 
CX1 male W18 110 0 0.0 0 0.0 2 100.0 2 
CR1 male W22 121 0 0.0 0 0.0 236 100.0 236 
 
Table 2. Quantification of germ cells in human gonads 
ID sex age sections  POU5F1+ DDX4-/low POU5F1+ DDX4+  DDX4+   total 
    (weeks.days) (n) nr germ cells % nr germ cells % nr germ cells % nr germ cells 
BA2 female W10.5 2 459 94.3 14 2.9 14 2.9 487 
CE1 female W14 6 421 14.6 5 0.2 2456 85.2 2882 
DK2 female W16.3 9 3841 61.5 0 0.0 2409 38.5 6250 
BE1 female W17 7 2683 45.6 0 0.0 3203 54.4 5886 
AL3 female W20 4 238 53.6 0 0.0 206 46.4 444 
DW3 female W21.5 8 1004 19.2 0 0.0 4234 80.8 5238 
BG2 male W10 3 266 69.1 116 30.1 3 0.8 385 
AT1 male W12 7 1827 65.1 880 31.3 101 3.6 2808 
AE2 male W14.2 8 1608 56.2 66 2.3 1187 41.5 2861 
CQ1 male W17 10 5551 83.1 62 0.9 1068 16.0 6681 
CT1 male W20 10 2690 36.4 0 0.0 4710 63.6 7400 
BW1 male W22 4 720 41.1 0 0.0 1032 58.9 1752 
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Embryo ID Sex Age (weeks of gestation) Adrenal Gonad
AV1 male W8.4 x
AH1 male W9.3 x
BG2 male W10 x x
AC1 male W11 x
AT1 male W12 x x
V1 male W12 x
AE2 male W14.2 x
AZ1 male W15.4 x
CV2 male W16.5 x
CQ1 male W17 x x
CX1 male W18 x
CT1 male W20 x
BW1 male W22 x
CR1 male W22 x
AQ1 female W8.6 x
AG1 female W9.1 x
AY1 female W9.6 x
AI3 female W10.4 x
BA2 female W10.5 x x
AQ2 female W11.4 x
DR3 female W13 x
CE1 female W14 x
DD2 female W16 x
DK2 female W16.3 x
BE1 female W17 x
BQ1 female W17.4 x x
CC2 female W18 x
DJ2 female W18 x
AL3 female W20 x
CD1 female W20.5 x
BM2 female W21 x
DW3 female W21.5 x
Total 23 14
Table S1. Number and sex of human organs anlysed.
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ABSTRACT 
Previously, X chromosome dosage compensation in the human pre-implantation embryos 
(E3-E7) was thought to be accomplished by reducing the expression of both X chromosomes, 
without X chromosome inactivation (XCI). Here, we investigated the status of XCI in human 
pre-implantation embryos at single cell level, by analyzing online available RNA-seq data of 
human E3-E7 pre-implantation embryos. We separated X-linked genes into genes subject to X 
inactivation (“X-sub”) and escapees (“X-esc”). Smaller proportion of biallelic expression in X-sub 
than in autosomal genes indicates one chromosome X is inactive in E4-E6 cells and E7 TE cells, 
whereas there is reactivation in E7 EPI and PE cells. Moreover, combined human androgen 
receptor gene (AR)/retinitis pigmentosa 2 (RP2)-based DNA methylation sensitive assay suggests 
non-imprinted X inactivation in human TE-derived cells, in contrast to mice.
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INTRODUCTION
The mechanism to achieve dosage compensation of X-linked genes between mammalian 
females and males is X chromosome inactivation (XCI), in which one of the two X chromosomes 
in female somatic cells is silenced [1, 2]. XCI is triggered by the spread of XIST RNA along the 
whole X chromosome [3], while there is no XIST transcription on the active X chromosome 
(Xa). Epigenetic markers of the inactive X chromosome (Xi) include trimethylation of histone 
H3 at lysine 27 (H3K27me3) [4], hypoacetylation of histone H4 [5, 6] and DNA methylation 
at CpG-rich promoters [7, 8]. In female somatic cells, most X-linked genes are subject to X 
inactivation (“X-sub”) and have monoallelic expression of either allele, whereas a fraction of 
genes escape X inactivation (known as escapees, “X-esc”) and have expression of both alleles. 
The percentage of escapees along human chromosome (Chr)X is around 15%, higher than the 
percentage in mice (about 3%) [9, 10]. Many of the escapees are located in the pseudoautosomal 
regions [11], where genes are present on both X and Y chromosomes. Moreover, some escapee 
genes are revealed to be tissue-specific (variable escapees) [12].
X inactivation has been investigated by several methods including XIST gene expression 
[13], H3K27 trimethylation [14], allele-specific expression (ASE) analysis [15], human androgen 
receptor assay (HUMARA) [16] and retinitis pigmentosa 2 (RP2)-based assay [17]. In ASE 
analysis, the informative single-nucleotide polymorphisms (SNPs) are able to assign parental 
origin of the expressed alleles, based on embryonic RNA sequence, embryonic and parental 
genome sequence [18]. However, in the absence of parental genome sequence, alleles for a 
SNP site can only be assigned to reference allele or alternative allele based on reference genome. 
Healthy individuals carry highly polymorphic microsatellite CAG repeat sequence in the first 
exon of human X-linked androgen receptor gene (AR) and polymorphic microsatellite GAAA 
repeat sequence in the promoter region of X-linked RP2 gene. The allele specific methylation of 
a 5’CpG island on AR locus and a CpG island in promoter of RP2 is reported to be associated 
with XCI [16, 17]. 
In mice, the dynamic X inactivation status during early development has been more 
extensively studied than in humans [19-21]. In mouse pre-implantation embryos, two separate 
waves of XCI have been revealed [19, 20, 22]. The first XCI wave occurs at the two- to four-cell 
stage, leading to the imprinted paternal X chromosome (Xp) inactivation in all blastomeres 
of the embryo [18]. The Xp remains inactivated in the trophectoderm (TE) and primitive 
endoderm (PE) during the development, whereas it becomes reactivated in the epiblast (EPI) at 
embryonic day (E)3.5. Shortly afterwards, either the Xp or the maternal X-chromosome (Xm) 
gets inactivated during the second XCI wave, resulting in random XCI in the EPI [23]. This is 
followed by reactivation of the silent X in mouse female primordial germ cells (PGCs) between 
E8.5 and E12.5, but not in the female somatic cells [14].
In humans, the inactivated X chromosome in PGCs becomes reactivated in 4 week 
embryos [15], having biallelic expression of X-genes. On the contrary, fetal somatic cells maintain 
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random inactivation and show monoallelic expression of X-genes. During pre-implantation 
development at E3-E7, X-genes in cells of pre-lineage and all lineages are thought to maintain 
biallelic expression [13, 24].
A recent study reveals that lineage segregation of EPI, PE and TE occurs at E5 in humans, 
using single-cell RNA-seq of E3-E7 embryos [25]. Before segregation, E3, E4 and immature 
E5 cells are referred to as “pre-lineage” cells. Several genes are identified to be enriched in EPI 
(PRDM14, GDF3, TDGF1, NODAL, SOX2, NANOG), PE (COL4A1, HNF1B, PDGFRA, 
GATA4, FN1) and TE (GATA2, GATA3) lineages. The algorithm “KeyGenes” (http://www.
keygenes.nl) [26] recently developed, as a tool to determine classifier genes for provided samples 
groups (training set), is able to identify genes either highly expressed or lowly expressed for pre-
lineage cells and cells of three lineages. In addition, KeyGenes predicts the identities of queried 
samples (test set) based on identity scores of test set to training set. 
Based on Ohno’s hypothesis, X-genes are upregulated twofold in order to achieve the 
gene dose balance between ChrX and autosomes [27]. The ratio of median expression level of 
X-linked genes to that of autosomal genes (X:A median expression ratio) [28-30] has been used 
to investigate X chromosome dosage compensation in female somatic cells and PGCs, with 
results supporting [28, 29] or rejecting [30] Ohno’s hypothesis. Additionally, the ratio of total 
expression level of X-linked genes to that of autosomal genes (X:A total expression ratio) [15] is 
another approach to investigate X chromosome dosage compensation. 
In this study, we investigated whether there was X inactivation in human pre-implantation 
embryos and whether the inactivation was imprinted or random, by systematic analysis of online 
available single-cell RNA-seq data and combined AR/RP2-based assay on human TE-derived cells. 
Our results indicate X inactivation in E4-E6 cells and E7 TE cells. Moreover, the X inactivation 
in human TE-derived cells is random, in contrast to mice. 
METHODS
Data acquisition 
From online available single-cell RNA-seq data of human E3-E7 pre-implantation 
cells (n=1519 cells from 87 embryos, karyotype 46,XX or 46,XY), FASTQ files of individual 
sequencing batches were accessed from the ArrayExpress database: E-MTAB-3929 [25], as well 
as the expression data in counts and Reads Per Kilobase Per Million (RPKM) files of all cells 
(n=1519). Previously published single-cell RNA-seq datasets of human gonadal cells of first and 
second trimesters (n=328 cells including somatic cells and PGCs) were obtained from the Gene 
Expression Omnibus (GEO) database (GEO: GSE63818) [15]. 
Expression levels and cells reassignment by KeyGenes 
Transcriptomic data in RPKM were primarily analyzed in R (version 3.2.5) (https://
cran.r-project.org/bin/windows/base/old/3.2.5/). Markers for pre-lineage, EPI, PE and TE, as 
well as epigenetic and pluripotency markers were used for multi-dimensional scaling (MDS) plot 
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exhibiting log2(RPKM+1), using R package “stats”. KeyGenes algorithm [26] was used to identify 
classifier genes for each cell type between E3-E7 and to confirm cell identities by generating their 
identity scores to cells representative of four cell types (as training set in KeyGenes). Cells were 
reassigned when prediction score was above 0.8 to the other cell types. Reassignments were used 
in further analysis. The heatmap showing log2(RPKM+1) was generated with R package “gplots” 
[31] with the same gene set as for MDS. 
Variant calling and annotation
All RNA-seq datasets were processed using the Gentrap pipeline developed at Leiden 
University Medical Center (http://biopet-docs.readthedocs.io/en/latest/pipelines/gentrap/). 
Gentrap pipeline consisted of FASTQ preprocessing (including quality control, quality 
trimming and adapter clipping), RNA-seq reads alignment to human reference genome, feature 
quantification at read or base level and variant calling. More specifically, FASTQ preprocessing 
was done using sickle (version 1.33) [32] (“sickle se -t sanger”). The RNA-seq reads were aligned 
to human reference genome GRCh38 [33] using GSNAP (version 2014-12-23) [34] (http://
research-pub.gene.com/gmap/) (“gsnap --format sam --nthreads 8 --db GCA_000001405.15_
GRCh38_no_alt_analysis_set --novelsplicing 1 --batch 4”). The sam to bam conversion, bam 
sorting and creation of mpileup files were performed using SAMtools (version 1.1) [35]. Varscan 
(version 2.3.7) [36] was then used on the mpileup output to call SNPs, with the following 
settings: min-coverage=8, min-reads2=2, min-avg-qual=15, min-var-freq=0.01, min-freq-for-
hom=0.75. The final outputs of the Gentrap pipeline were multi-sample VCF files. In our 
study, genotypes in RNA-seq data were called on sites where common variants occur. R package 
“VariantAnnotation” [37] was used to acquire genotype (0=reference allele, 1=alternative allele), 
alternative allele and reference allele read counts from VCF files. The variants were annotated using 
the SeattleSeq Annotation [38], with GRCh38 as the source genome (http://snp.gs.washington.
edu/SeattleSeqAnnotation144/). 
Median expression and total expression of ChrX and autosomes 
For each pre-implantation cell, median and total expression of autosomal genes, X-sub 
and X-esc genes was calculated by the median expression of all transcribed genes (RPKM>0) and 
by the sum of all the transcribed genes (in RPKM).
X:A median (and total) expression ratios between female and male cells of the same cell 
type at the same embryonic day were compared, using R packages “gdata” [39] and “lme4” [40]. 
Female-to-male median (and total) expression ratio was calculated by median value of female/
male X:A median (and total) expression ratios. 
Proportion of biallelic expression in X-linked and autosomal genes
Female pre-implantation cells and fetal cells were included for biallelic expression 
analysis. Genotypes were called at common SNP sites located in gene coding regions with high 
frequency in the general population. All SNP sites with minor allele frequency (MAF)≥5% in 
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the 1000 Genomes Project (https://www.ncbi.nlm.nih.gov/variation/docs/human_variation_
vcf/#common_all) were selected. Then cells with genotype calls (including reference calls) at 
minimum 2000 SNP sites were included for further analysis. For these cells, biallelic expression 
proportion in each cell type at each embryonic day was shown in boxplots, using relevant R 
packages (“VariantAnnotation”, “ggplot2” [41] and “plyr” [42]). Biallelic expression proportion 
between X-linked genes (X-sub and X-esc, separately) and autosomal genes was compared using 
the statistical approach of “Generalized linear mixed model fit by maximum likelihood (Laplace 
Approximation) [glmerMod])”, using R packages “gdata” [39] and “lme4” [40]. 
Allele-specific expression analysis
X-SNP sites with expression of both reference and alternative alleles in individual 
embryos, were considered to be heterozygous in embryonic DNA and therefore were selected 
for ASE analysis. For these SNPs, read counts of reference and alternative alleles in each cell of 
individual embryos were plotted using R packages “VariantAnnotation”, “ggplot2”, “reshape2” 
[43], “plyr”, “stringr” [44], “gridExtra” [45] and “dplyr” [46]. 
TE-derived cells collection from human blastocyst outgrowths
This work was approved by the Ghent University Hospital Ethical Committee (PROJECT 
#2009/281) and the Belgian Federal Ethical Committee on Embryo Research (PROJECT 
#ADV022). All embryos were obtained with written informed consent signed by the donor 
couples undergoing in vitro fertilization (IVF) at the Center for Reproductive Medicine of 
Ghent University. Day 3 cryopreserved embryos were thawed and cultured to E7 blastocyst stage 
at 37°C, 6% CO2 and 5% O2. After extra 6 days culture, TE-derived cells were isolated from the 
blastocyst outgrowths, half used for sex determination and the other half for DNA methylation 
assay.
Genomic DNA was extracted from the TE-derived cells. For this, we digested each sample 
by adding 80μl proteinase K buffer, 260μl of RNase free H2O, 20μl of 10% SDS and 10μl of 
proteinase K (10 mg/μl) (Promega, catalog #V3021, Madison, WI, USA). Then the mixture 
was incubated on a thermal mixer at 55°C , 750 revolutions per minute (RPM) overnight. After 
enzyme inactivation (95°C, 10 minutes), we added 120μl 5M ice cold NaCl to the sample. 
The tube was repeatedly inverted to mix and then centrifuged at 0°C for 5 minutes at 13000 
RPM. After centrifugation, 400μl of the supernatant was transferred to a clean tube, and 1ml 
of ice cold 95% ethanol was added. After incubation at -20°C for one hour, each sample was 
centrifuged at 0°C for 5 minutes at 13000 RPM and the supernatant was discarded. 1ml of ice 
cold 70% ethanol was added and each sample was centrifuged once more at 0°C for 5 minutes 
at 13000 RPM, after which the supernatant was discarded. Polymerase chain reaction (PCR) for 
AMELX/Y was performed to detect embryos gender as reported [47]. 
Human combined AR and RP2-based methylation assay
DNA digestion with CpG methylation sensitive restriction enzyme HpaII (R0171S, 
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New England Biolabs, Ipswich, MA, USA) was carried out at 37°C overnight, followed by 
incubation at 65°C for 20 minutes to inactive the enzyme. Afterwards, fluorescent tagged 
primers for gene AR (FAM-5’-TCCAGAATCTGTTCCAGAGCGTGC-3’ and anti-
sense primer 5’-GCTGTGAAGGTTGCTGTTCCTCAT-3’) and for gene RP2 (FW-5’-
TGACATAGCGAGACCCTGTG-3’, RV-5’- TGGTGGGTTCTCTAGCTGGT-3’) were used 
for DNA amplification, with a PCR cycle of 95°C for 3 minutes, 35 times 95°C for 45 seconds, 
60°C for 30 seconds, 72°C for 30 seconds and a final extension step at 72°C for 10 minutes. 
 Fragment analysis was performed at the Leiden Genome Technology Centre (LGTC; 
http://www.lgtc.nl) using a 96-capillary ABI PRISM® 3730xl DNA analyzer (Applied Biosystems, 
Carlsbad, CA, USA). AR and RP2 alleles were distinguished and quantified through capillary 
electrophoresis by exploiting the variable glutamine repeat present on the amplified region of the 
AR locus [16, 48], using Peak Scanner Software v2.0 (Applied Biosystems, Carlsbad, CA, USA).
Percentage of Xp methylation for the amplified AR and RP2 region was calculated [49], 
meaning that 50% indicated a 1:1 ratio in which each parental allele was equally methylated. 
Exclusive inactivation of the maternal or paternal allele meant 0% or 100% of Xp methylation 
respectively. Skewed maternal or paternal XCI was considered present when the percentage of 
paternal methylation was ≤25% or ≥75% respectively.
RESULTS 
Cell identities in human pre-implantation embryos
We analyzed existing high-quality single-cell transcriptome dataset of 1519 cells from 87 
human pre-implantation embryos (N=44, female; N=43, male) at E3 (n=81, N=13), E4 (n=190, 
N=16), E5 (n=367, N=23), E6 (n=415, N=18) and E7 (n=466, N=17) [25]. 
Based on expression profile in RPKM of all the 1519 E3-E7 cells, MDS with a set of 
carefully selected 126 genes (S1 Table) separated pre-lineage cells at E3-E5 from cells of three 
lineages (EPI, PE and TE) at E5-E7 in the first dimension (Dim1) (Fig 1A, S1A Fig). This gene 
set (S1 Table) included reported pre-lineage markers, markers for three lineages [25, 50] as well 
as known epigenetic and pluripotency markers. Along the second dimension (Dim2), TE cells 
were separated from inner cell mass (ICM; EPI+PE) cells at E5-E7 (S1A Fig). MDS on E7 cells 
separated TE cells from ICM cells in Dim1 and separated EPI from PE cells in Dim2 (S1A Fig).
With KeyGenes algorism, we first determined the identifier genes for pre-lineage and 
three lineages, and then confirmed identities of cells and also reassigned the mislabeled cells. 
Since lineage segregation was already complete at E7, we chose 26 E7 representative cells for EPI 
(n=9), PE (n=8) and TE (n=9) as training set 1 (cells marked by black circles in S1A Fig). The 
classifier genes were INPP5D, NANOG, PRDM14, PSORS1C2 for E7 EPI lineage, COL4A1, 
FN1, HNF1B, LGALS2 for E7 PE lineage and GPRC5B, IL6R for E7 TE lineage (S1A Fig). 
Identities of E6 (n=415) and E7 (n=466) cells, as test set 1, were predicted by KeyGenes based 
on training set 1. With prediction score above 0.8 as the cutoff, 10 E6 cells and 4 E7 cells were 
found to be mislabeled and subsequently reassigned by KeyGenes (S2 Table). Next, to determine 
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identifiers for pre-lineage and to predict identities of E5 cells, we combined training set 1 (n=26) 
with E4 cells (n=10) clustered closer to E5 cells in MDS as training set 2 (n=36, cells marked by 
black circles in S1B Fig). The identified classifier genes were ETNPPL, HINT1, TPM4, VOM1 
for E4 pre-lineage, GDF3, NANOG, NODAL, VENTX for E7 EPI lineage, COL4A1, CTSE, 
HNF1B, LGALS2, RSPO3 for E7 PE lineage and ALPL, CFLAR, GPR160, KLF4, POU5F1 for 
E7 TE lineage (S1B Fig). Identities of E5 cells (n=367), as test set 2, were predicted by KeyGenes 
based on training set 2. A total of 48 E5 cells were reassigned with prediction score>0.8 (S2 
Table). With reassigned identities, cell components of all 87 embryos were shown in Fig 1B.
Compared to the original cell identities (S1B Fig), MDS on reassigned cells (Fig 1C, S2 
Table) provided more clear segregation of pre-lineage cells and cells of three lineages in Dim1. 
Based on expression of the 126 genes of interest, heatmap on reassigned cells gave sub-clusters 
of E3 pre-lineage, E4 pre-lineage, E5 pre-lineage, E4-E5 pre-lineage, PE, EPI and TE lineages 
(S2 Fig). 
X:Autosome expression ratio during human pre-implantation development
To study dosage compensation in females and males between E3-E7, we used both 
approaches (X:A median expression ratio and X:A total expression ratio) to compare X-linked 
genes and autosomal genes expression. Since escapees have biallelic expression and may potentially 
increase gene dose of X-genes in females, we separated X-linked genes into two categories: X-esc 
(92 genes, S3 Table) [11, 51-54] and X-sub.
 First, for each of the 1519 cells between E3-E7, we calculated median expression of all 
genes with RPKM>0 for all 22 pairs of autosomes (~22280 genes), X-sub (~840 genes) and 
X-esc (~60 genes) (S3 Fig). Between E3-E7, X-sub:A median expression ratios ranged from 0.39 
to 1.39 in females (median=0.86) and from 0.31 to 1.17 in male cells (median=0.71) (Fig 1D, 
left panel; S4 Table), while X-esc:A median expression ratios ranged from 0.46 to 6.21 in female 
cells (median=1.99) and from 0.50 to 3.01 in males (median=1.50) (Fig 1D, right panel; S4 
Table). X-sub:A median expression ratios and X-esc:A median expression ratios in female and 
male cells of each type at each embryonic day were shown in S4 Table. 
We compared the X:A median expression ratios between females and males of the same 
cell type at the same embryonic day. In most cases, female cells at E3-E7 showed significantly 
higher X-sub:A median expression ratios and X-esc:A median expression ratios than male cells 
(Fig 1D, S4 Table). While female cells of E7 EPI and E7 PE had comparable X-sub:A median 
expression ratios to male cells of EPI and PE at E7 (Fig 1D, S4 Table), we observed comparable 
X-esc:A median expression ratios between female and male cells of E5 PE, E5 TE, E6 EPI and 
E6 PE lineages (Fig 1D, S4 Table). To further study female-to-male X chromosome dosage, we 
calculated relative X-sub:A median expression ratio between females and males (Fig 1E). Female-
to-male X-sub:A median expression ratios ranged from 1.09 (in E7 TE) to 1.42 (in E6 PE) (Fig 
1E, S4 Table), being higher than 1 between E3-E7. Female-to-male X-esc:A median expression 
ratios ranged from 1.19 (in E6 PE) to 1.60 (in E7 PE) (Fig 1E, S4 Table), being higher than 1 
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between E3-E7.
Next, we summed the RPKM values of transcribed (RPKM>0) autosomal genes, X-sub 
and X-esc genes for each cell (S4A Fig). The X-sub:A total expression ratios ranged from 1.20% to 
4.93% in female cells (median=2.77%) and from 0.77% to 2.84% in male cells (median=1.69%) 
(S4B Fig, left panel; S4 Table), whereas the X-esc:A total expression ratios ranged from 0.33% to 
1.54% in female cells (median=0.77%) and from 0.17% to 1.08% in male cells (median=0.50%) 
(S4B Fig, right panel; S4 Table). Using the same statistic method as above, we compared females 
and males of the same cell type at the same day. We observed significantly higher X:A total 
expression ratios in females than males in all cases at E3-E7 (S4B Fig). Female-to-male X-sub:A 
total expression ratios ranged from 1.26 (in E7 TE) to 2.00 (in E5 pre-lineage) (S4C Fig, S4 
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ranged from 1.28 (in E3 pre-lineage) to 1.88 (in E7 EPI) (S4C Fig, S4 Table), being higher than 
1 between E3-E7. 
Smaller proportion of biallelic expression in X-sub than in autosomal genes 
at E4-E7
To investigate XCI in female pre-implantation embryos, especially the embryos with 
different cell types, we excluded embryos with less than 5 cells and/or with only TE cells, 
resulting in 692 cells from female embryos (N=30) at E3 (n=26, N=4), E4 (n=84, N=6), E5 
(n=139, N=7), E6 (n=196, N=6) and E7 (n=247, N=7) (S5 Table). Moreover, from another 
publicly available single-cell RNA-seq dataset [15], we included female fetal PGCs (n=10, N=2) 
and fetal somatic cells (n=38, N=5) as XaXa controls (with biallelic expression of X-sub genes) 
and XaXi controls (with monoallelic expression of X-sub genes) respectively. 
According to 1000 Genomes Project, each SNP of X-linked genes and autosomal 
genes has its own MAF in human population. In order to achieve similar possibilities of being 
heterozygous for SNPs on X-linked genes and autosomal genes, SNPs located in gene coding 
regions with MAF≥5% in global human population were included in the analysis, 2502 SNPs 
on ChrX and 11395 SNPs on autosomes. 
Single cells with less than 2000 SNPs were excluded from further analysis. Cells included 
were 10 fetal PGCs (N=2) and 34 fetal somatic cells (N=5) and 513 pre-implantation cells [E3 
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For each cell, we calculated the proportion of biallelic expression (“Pro-bi”) in all the SNP sites 
detected in autosomal genes and X-linked genes (X-sub and X-esc, separately) (Fig 2). Then we 
compared the Pro-bi between autosomal genes and X-linked genes (X-sub and X-esc, separately) 
in fetal PGCs, fetal somatic cells and pre-implantation cells of each cell type at each embryonic 
day (Fig 2). 
In fetal PGCs (XaXa controls) and somatic cells (XaXi controls), Pro-bi between X-esc 
and autosomal genes were comparable (Fig 2A). Nevertheless, when Pro-bi between X-sub 
and autosomal genes were comparable in fetal PGCs, Pro-bi in X-sub was significantly lower 
than in autosomal genes in fetal somatic cells (P values shown in Fig 2A). Results suggest that 
our method of comparing the Pro-bi between X-sub genes and autosomal genes is reliable to 
investigate XCI in female cells. Pro-bi between X-esc and autosomal genes were comparable 
in most cell categories at E3-E7 (Fig 2A-F) except in E6 TE (n=93) (Fig 2E). In E3 cells, no 
significant difference was detected in Pro-bi between X-sub and autosomal genes (Fig 2B). In 
contrast, E4 cells had significantly lower Pro-bi in X-sub than in autosomal genes (Fig 2C). This 
indicates X inactivation wave occurring between E3-E4 in human embryos. At E5, Pro-bi was 
significantly lower in X-sub than in autosomal genes in pre-lineage (n=44), EPI (n=20) and 
TE cells (n=19) (Fig 2D), suggesting X inactivation in these cell types at E5. Pro-bi in X-sub 
was found to be comparable to that in autosomal genes in E5 PE cells (n=4) (Fig 2D), where 
statistical comparison might not be powerful enough to get conclusion on E5 PE cells. In all 
three lineages at E6 (EPI, n=26; PE, n=17; TE, n=93), Pro-bi was significantly lower in X-sub 
than in autosomal genes (Fig 2E), suggesting X inactivation in E6 embryos. Pro-bi in X-sub 
stayed significantly lower than in autosomal genes in E7 TE cells (n=180) (Fig 2F), whereas in E7 
EPI (n=21) and PE cells (n=7), Pro-bi in X-sub became comparable to that in autosomal genes 
(Fig 2F). Together, results indicate X inactivation in E4-E6 embryos and E7 TE cells, followed 
by reactivation in E7 EPI and PE cells.  
Random X inactivation in TE-derived cells
To further study whether the XCI pattern in these pre-implantation embryos was imprinted 
or random, we performed allele-specific expression analysis of X-linked genes compared to 
autosomal genes in individual E3-E7 female embryos (Fig 3). The numbers of expressed genes on 
Chr8 and Chr14 were comparable to ChrX in all E3-E7 cells (S6 Table). While Chr8 and Chr14 
had comparable numbers of SNP sites with biallelic expression in individual E3-E7 embryos, 
the SNP sites with biallelic expression on ChrX were around half as many as those on Chr8 and 
Chr14 in each embryo (Fig 3A). Within individual E3-E7 embryos, SNP sites of X-sub genes 
showed monoallelic expression in some cells, and not restricted in a certain lineage even in E7 
embryos (Fig 3B), while SNP sites on autosomes had biallelic expression in almost all the cells, as 
well as the SNP sites of X-esc genes (Fig 3B). Without genome sequence of the embryos, we were 
not able to determine the XCI pattern in embryos by allele-specific expression analysis. 
Therefore, we continued investigating XCI pattern by another approach of exploring 
DNA methylation at CpG island of X-linked genes. For this, we performed combined human 
58
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AR/RP2-based assay on TE-derived cells of 8 male and 15 female human blastocyst outgrowths 
from 8 IVF cycles (S7 Table). 
To determine the parental origin of AR and RP2 alleles for female TE-derived cells, 
we first analyzed the maternal AR and RP2 allele sizes in male TE-derived cells which held 
an unmethylated maternal allele but no paternal allele (Fig 4A). Female TE-derived cells with 
a single major peak in either AR or RP2 gene in undigested DNA samples were considered 
as homozygous and therefore excluded from further analysis. Afterwards, for each female TE-
derived cell sample, we calculated the percentage of paternal allele methylation as previously 
reported (Fig 4B) [49]. 
The percentage of paternal allele methylation for both genes in all female embryo 
outgrowth ranged from 33.3% - 68.6% (Fig 4B, S7 Table). Results showed equal methylation 
of each parental allele, suggesting random monoallelic expression of X-linked genes in these 
embryo outgrowth samples. Taking together with the observed smaller proportion of biallelic 
expression in X-sub than in autosomal genes in E7 TE cells, we conclude that human TE cells 
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DISCUSSION 
Well-studied genetic substrains of mice made the allele-specific expression analysis of XCI 
in mouse pre-implantation embryos possible [18], whereas parental allelic origin is often not 
available for human embryos. 
Analysis of RNA-seq data for human adult tissues showed that X-linked:A median 
expression ratio ranged from 0.34 to 0.70 in 6 male tissues (median=0.53) and from 0.42 to 0.47 
in 4 female tissues (median=0.46) [30]. In another study on RNA-seq data for lymphoblastoid 
cell lines, X-linked:A median expression ratios were 0.64±0.07 in males (n=24) and 0.66±0.07 in 
females (n=17) [28] when all transcribed genes (RPKM>0) were included. Moreover, X-linked:A 
median expression ratios were revealed to increase depending on RPKM cutoffs (>0, ≥1, ≥2) of 
gene inclusion [28]. 
In our study, X-linked genes were separated into X-sub and X-esc categories since escapees 
might have increased dose in females than in males, even though some studies did not show 
significant differences in escapees expression level between sexes [30, 55]. Our results showed 
higher X-esc:A median expression ratios than X-sub:A median expression ratios in females and 
males at E3-E7 (Fig 1D), indicating upregulation of these escapee genes in females and males 
compared to X-sub genes. E7 EPI and E7 PE female cells had comparable X-sub:A median 
expression ratios to males (Fig 1D), indicating X chromosome dosage compensation in E7 cells 
of EPI and PE lineages. When dose of X-sub genes in female cells was normalized to males (Fig 
1E), we observed lower female-to-male ratio at E7 compared to other embryonic days. 
Without genome sequencing data, only the SNPs with biallelic expression or random 
monoallelic expression could be detected as informative SNPs. Therefore, SNPs having 
monoallelic expression within an embryo can be a result of homozygous SNPs in DNA or the 
imprinted inactivation in all the cells of this embryo. Our approach of comparing the Pro-bi 
between X-sub genes and autosomal genes was suggested to be reliable in XCI investigation 
by its performance in XaXa and XaXi controls (Fig 2A). Smaller Pro-bi in X-sub than in 
autosomes was detected in E4 cells, indicating X inactivation wave occurring between E3-E4 
in human embryos. Then the Xi remains silent at E5-E6 until its reactivation in E7 EPI and 
E7 PE lineages. Here, we describe the dynamic XCI status during human pre-implantation 
development, in contrast to the previous reported biallelic expression in all cell types between 
E3-E7 [25]. Results strongly contrast with the previous hypothesis that both X chromosomes are 
active during human pre-implantation (E3-E7) development [25]. This is because in the allele-
specific expression analysis of Petropoulos and colleagues [25], without genome sequencing data, 
only the SNPs with biallelic expression or random monoallelic expression could be detected as 
informative SNPs. Therefore, SNPs having imprinted monoallelic expression within an embryo 
would have been missed in the analysis. In addition, those genes with biallelic expression could 
be X-esc genes at human pre-implantation stage. In another study using RNA FISH for X-linked 
genes to detect XCI, ATRX gene shows biallelic expression in most cells of E5 female blastocysts 
61
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(without separation of ICM from TE) [13]; however, ATRX gene is an X-Y paired gene (thus an 
escapee) [54] which is supposed to have biallelic expression even on the inactive ChrX. The first 
XCI wave in mouse pre-implantation embryos occurs at the two- to four-cell stage [18] while 
in humans it happens between E3-E4. This difference is probably due to the different timing of 
zygotic genome activation (ZGA) in mice (at two cell stage [18]) and in humans (at E4 [25, 56]).
Combining X-sub:A median expression ratios in female cells (Fig 1D) and comparison 
results from Pro-bi between X-sub and autosomal genes (Fig 2B-F), we hereby conclude that 
two X chromosomes are Xa(non-upregulated)Xa(non-upregulated) in E3 cells, Xa(upregulated)
Xi(inactive) in E4 cells, Xa(upregulated)Xi(inactive) in E5 pre-lineage, E5 EPI, E5 TE, E6 EPI, 
E6 PE and E6 TE cells, Xa(non-upregulated)Xa(non-upregulated) in E7 EPI and E7 PE cells, 
Xa(upregulated)Xi(inactive) in E7 TE cells (S4 Table). 
The SNP sites with biallelic expression on autosomes (Chr8 and Chr14) were twice as 
many as those on ChrX in individual E3-E7 embryos (Fig 3A). This may be due to the silence of 
one X chromosome and monoallelic expression of X-genes. Moreover, in allele-specific expression 
analysis of X-sub genes, some cells had expression of both alleles whereas monoallelic expression 
was observed in other cells of the same embryo (Fig 3B). These genes could be escapees at human 
pre-implantation stage. 
In combined AR/RP2 methylation assay, bulk female TE-derived cells showed equal 
methylation of paternal and maternal alleles in both AR and RP2 locus, indicating expression of 
both alleles and therefore random inactivation in human TE-derived cells, which is in contrast 
to the imprinted XCI in mouse TE cells.
In conclusion, we propose that in human pre-implantation embryos, both X chromosomes 
are active at E3 and one of them becomes inactive at E4. The Xi remains silent at E5-E6, followed 
by reactivation in EPI and PE at E7. In E7 TE, X inactivation stays and it is in a random pattern. 
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ABSTRACT
In humans, the defective invasion of the maternal endometrium by fetal extravillous 
trophoblasts (EVTs) can lead to insufficient perfusion of the placenta, resulting in pregnancy 
complications that can put both mother and baby at risk. To study the invasion of maternal 
endometrium between (W)5.5-12 weeks of gestation by EVTs, we combined fluorescence in situ 
hybridization, immunofluorescence and immunohistochemistry to determine the presence of 
(male) EVTs in the vasculature of the maternal decidua. We observed that interstitial mononuclear 
EVTs directly entered decidual veins and lymphatics from W5.5. This invasion of decidual veins 
and lymphatics occurred long before endovascular EVTs remodelled decidual spiral arteries. This 
unexpected early entrance of interstitial mononuclear EVTs in the maternal circulation does not 
seem to contribute to the materno-placental vascular connection directly, but rather to establish 
(and expand) the materno-fetal interface through an alternative vascular route.
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INTRODUCTION
During human placental development, at the tips of the anchoring villi, cytotrophoblasts 
proliferate into cell columns and from there they can detach and invade the maternal decidualized 
endometrium (decidua) and even the myometrium [1, 2]. Those invading fetal cytotrophoblasts 
are known as extravillous trophoblasts (EVTs). 
At term, there are several subtypes of EVTs present in the maternal decidua, depending on 
their localization: the interstitial mononuclear (as well as multinuclear) EVTs are dispersed in the 
decidual mesenchyme; the endovascular EVTs and intramural EVTs are both directly associated 
with remodeled spiral arteries and are present in their lumen (or replacing the endothelial cells) 
and in their tunica media [3] respectively and those EVTs migrate-colonize the spiral arteries in 
a retrograde fashion [4]; and a fourth category of ‘epithelial’ EVTs lines, together with maternal 
endothelial cells in a mosaic fashion, the basal plate of the maternal decidua basalis [5]. 
In humans, the defective invasion of the maternal decidua by fetal EVTs leads to 
insufficient perfusion of the placenta, resulting in pregnancy complications, such as intrauterine 
growth restriction, (recurrent) spontaneous abortion, (very) premature birth and preeclampsia 
[6, 7]. The unique vascular remodeling of the maternal decidua during pregnancy, whereby both 
fetal and maternal cells play complementary regulatory roles, is a fundamental process for a 
successful pregnancy [8, 9]. 
Endovascular EVTs are observed in spiral arteries from (W)8 weeks of gestation, ‘plugging’ 
(or blocking) the entrance of spiral arteries to the intervillous space preventing maternal blood 
flow until about W12 [10-12]. During this period (W8-W12), decidual veins become dilated 
in both decidua parietalis and basalis to give rise to decidual venous lakes [13]. By W12, both 
decidual veins and spiral arteries are in open connection with the intervillous space of the placenta 
allowing the maternal blood to circulate between the placental villi [10-12]. This materno-
placental vascular connection provides efficient exchange of nutrients, waste products, hormones 
and gases between the maternal blood and the fetal blood and is crucial to ensure fetal growth.
 After the materno-placental vascular connection is established, the constant maternal 
blood flow transports small tissue fragments (syncytial knots) that are shed from the outer layer 
of the placental villi of multinucleated (non-viable) syncytiotrophoblasts into the decidual 
venous where those knots become trapped and are subsequently cleared [13-15]. If the syncytial 
knots escape to enter the maternal circulation, they can cause trophoblastic embolism and even 
sudden death of the mother [16]. 
Interestingly, the presence of fetal cells [17], placental-derived particles and exosomes [18, 
19] in the maternal blood from W6 has been described, but in the absence of robust materno-
placental vascular connection this remains to be clarified. Therefore, we sought to systematically 
characterize the presence of EVTs in the endometrium in the period W5.5-W12. Our results 
indicate that between W5.5-W12, interstitial mononuclear EVTs efficiently enter the maternal 
(blood and lymph) circulation. This novel aspect of EVT invasion, enlarging materno-fetal 
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interface early during pregnancy, may shed new light in our understanding of pregnancy 
complications and maternal immune tolerance.
MATERIALS AND METHODS
Ethics approval and human tissue collection
The Medical Ethics Committee of the Leiden University Medical Center (protocol 
P08.087) approved the collection and use of material for this study. Written informed consent 
was obtained from all patients (N=13). Tissue was obtained by vacuum aspiration from 
women undergoing voluntary pregnancy termination without medical indication and obtained 
anonymized. The gestational age (in weeks and days) was determined by obstetric ultrasonography 
and can be converted to weeks post conception by subtracting two weeks. Tissue samples (S1 
Table) were collected in cold saline solution (0.9% NaCl). The decidua basalis and parietalis 
were identified retrospectively by the presence of scattered pKRT-positive EVTs in histological 
sections. 
Sex genotyping and histochemistry 
The material was sex genotyped by polymerase chain reaction (PCR) for AMELX/AMELY 
as previously described [20]. The decidua was fixed in 4% paraformaldehyde (PFA) overnight at 
4ºC, paraffin embedded and sectioned as previously described [20]. For Azan staining, paraffin 
sections were deparaffinised using xylene and dehydrated by standard procedures. The sections 
were then treated with 0.1% Azocarmine B (Edward Gurr Ltd., London, UK) in 5% glacial 
acetic acid (Merck, Darmstadt, Germany) for 3 minutes, rinsed several times in water, treated 
with 5% phosphotungstic acid (Fluka, Sigma-Aldrich, St. Louis, USA) solution for 6 minutes, 
again rinsed several times in water and immersed in a 1:1 solution of water to 0.4% orange G 
(Merck, Darmstadt, Germany)/0.2% aniline blue (Nustain, Nottingham, UK) in 1% glacial 
acetic acid for 15 minutes, all at room temperature (RT). Sections were then rinsed in water, 
dehydrated through a series of ethanol solutions, xylene and mounted in Entellan (Merck, 
Darmstadt, Germany).
Immunofluorescence
Paraffin sections were deparaffinised using xylene and dehydrated by standard procedures 
and used for immunofluorescence as previously described [20]. Briefly, antigen retrieval was 
performed in citrate buffer, followed by treatment with blocking solution consisting of 1% 
bovine serum albumin (BSA; Sigma-Aldrich, St. Louis, USA) in 0.05% PBST [0.05% Tween-20 
(Merck-Schuchardt, Hohenbrunn, Germany) in phosphate-buffered saline (PBS)] for 40 minutes 
at RT. Sections were then incubated with the primary antibodies diluted in blocking solution 
for 1 hour at RT, washed twice in PBST for 5 minutes and incubated with secondary antibodies 
diluted in blocking solution for 1 hour at RT. The primary antibodies used were mouse anti-pan-
keratin (pKRT; 1:100; AE1/AE3, Dako, Heverlee, Belgium), rabbit anti-platelet/endothelial 
adhesion molecule 1 (PECAM1; 1:200; sc1506-R, Santa Cruz Biotechnology, Santa Cruz, CA, 
75
Human EVTs invasion | 
4
USA), rabbit anti-alpha-smooth muscle actin (ACTA2; 1:200; ab5694, Abcam, Cambridge, 
UK), mouse anti-podoplanin (PDPN; 1:100; ab77854, Abcam, Cambridge, UK) and rat anti-
PDPN (1:100; 12-9381-42, eBioscience, San Diego, CA, USA). The secondary antibodies 
used were Alexa Fluor 594 donkey anti-mouse IgG (1:500; A-21203), Alexa Fluor 488 goat 
anti-rabbit IgG (1:500; A-11034), Alexa Fluor 555 goat anti-rat IgG (1:500; A-21434), Alexa 
Fluor 488 donkey anti-mouse IgG (1:500; A-21202) and Alexa Fluor 647 donkey anti-rabbit 
IgG (1:500; A-31573) (all from Life Technologies, Eugene, OR, USA). Nuclei were stained 
with 4',6-diamidino-2-phenylindole (DAPI; Vector Laboratories Ltd., Peterborough, UK) 
and sections were mounted in Prolong Gold anti-fade reagent (Life technologies). As negative 
controls, slides were immunostained omitting the primary antibodies.
Fluorescence in situ hybridization (FISH) for chrX and chrY 
FISH with probes of human chrX and chrY was carried out to distinguish fetal (male) 
cells from maternal (female) cells. After selected immunostained slides were imaged, they were 
incubated with 0.4% pepsin (pepsin from porcine gastric mucosa, P7000-100G, Sigma-Aldrich, 
St Louis, MO, USA) in 0.02M HCl for 5 minutes at 37°C. Centromere specific alphoid repeat 
probes used were pBamX5 and pDP97 of the human chrX and chrY, respectively [21, 22]. Both 
probes were labeled by nick translation with FITC (chrX probe) or Cy3 (chrY probe). Probe 
labeling and hybridization reaction were performed using previously published protocols [23, 
24].
Image acquisition
Slides were either scanned on a Pannoramic 250 FLASH digital scanner (3D HISTECH 
Ltd., Budapest, Hungary) and representative areas selected for images using the software program 
‘Pannoramic viewer’ (3D HISTECH Ltd., Budapest, Hungary); or photographed on a Leica 
DMRA fluorescence microscope (Leica, Wetzlar, Germany) equipped with a CoolSnap HQ2 
camera (Photometrics, Tucson, USA). Figures were compiled using Photoshop CS6 (Adobe 
Systems Inc., San Jose, USA).
Quantification of veins being invaded by EVTs
The combination of Azan staining and immunofluorescence for ACTA2, PECAM1 and 
PDPN on serial sections from the decidua basalis enabled us to distinguish decidual veins from 
arteries and lymphatic vessels. Decidual veins were PECAM1-positive, ACTA2-negative and 
PDPN-negative vessels, with reduced amounts of extracellular matrix surrounding them. Veins 
were considered invaded when there were one or multiple (male) EVTs (KRT-positive, chrY-
positive) penetrating the (maternal) vessel wall (chrY-negative, PECAM1-positive, ACTA2-
negative and PDPN-negative). To quantify the percentage of decidual veins invaded by EVTs, 
we manually counted decidual veins (with and without EVTs invasion) in each paraffin section 
of decidua basalis of different individuals (N=9) between W5.5-W12. The number of paraffin 
sections (n) counted is shown. The results are shown as mean±standard deviation.
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RESULTS
Interstitial mononuclear EVTs invade decidual veins from W5.5-W7.5 
We investigated the presence of (male) EVTs in the decidua in the period W5.5-W12 and 
have analyzed a total of n=19 samples of decidua basalis and n=20 decidua parietalis from N=13 
women (S1 Table). Due to a paucity of markers to identify specifically EVTs, we used a combined 
approach of cytogenetics (FISH for sex chromosomes chrX and chrY) and immunofluorescence 
for pan-keratin (pKRT) to distinguish maternal glandular epithelial cells from the fetal (male) 
EVTs in the endometrium (S1 Fig). This staining-combination also allowed us to distinguish 
decidua parietalis from decidua basalis (S1 Fig). Combining cytochemistry (Azan staining) and 
immunofluorescence for the arterial-marker ACTA2, the endothelial-marker PECAM1 and the 
lymphatic-marker PDPN, we were able to differentiate between arteries, veins and lymphatic 
vessels. 
Surprisingly, between W5.5-W7.5 in the decidua basalis, we detected invasion of (non-
dilated) ACTA2-negative PECAM1-positive decidual (maternal) veins by (male) individual 
interstitial mononuclear EVTs (Fig 1A-E). These (male) EVTs were clearly observed penetrating 
the endothelial wall of decidual veins, often in consecutive sections (Fig 1B) in all the W5.5-W7.5 
decidua basalis analyzed (n=9 from N=6 individuals). We counted decidual veins in paraffin 
sections (n=40) from different individuals between W5.5-W7.5 (N=4), and observed that on 
average 17% (147/856) of the decidual veins were invaded by EVTs (Fig 1E, orange bars).
By contrast, individual interstitial mononuclear EVTs were always observed outside the 
arterial smooth-muscle layer of the ACTA2-positive PECAM1-positive decidual spiral arteries, 
even in those arteries located close to the maternal basal plate and in the vicinity of EVTs (Fig 2).
From W8-W12, mononuclear EVTs invade spiral arteries as well as decidual 
veins
Between W8-W12 (N=7), interstitial mononuclear EVTs were still observed penetrating 
many decidual veins both close to the basal plate and more interiorly located (Fig 3A-B and S2 
Fig). We counted decidual veins in paraffin sections (n=47) from different individuals between 
W8.1-W12 (N=5), and observed that on average 16% (165/1038) of the decidual veins were 
invaded by EVTs (Fig 1E, blue bars), comparable to what was observed between W5.5-W7.5. At 
this gestational age, many decidual spiral arteries located at the maternal basal plate were indeed 
being remodeled and contained endovascular and intramural EVTs in the lumen and tunica 
media, respectively (Fig 3C). However, we noticed that deeper located decidual spiral arteries 
remained unremodelled, whereas neighboring deeper located veins were consistently invaded by 
individual interstitial mononuclear EVTs in all decidua basalis analyzed (Fig 3B-C and S2 Fig).
From the decidual samples analyzed in this study, cytogenetic analysis revealed that one 
individual decidua was from a W8.4 conceptus with Klinefelter syndrome (mosaic 47,XXY and 
46,XY) (Fig 4A), even though additional chromosomal abnormalities were not investigated. 
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Importantly, interstitial mononuclear XXY EVTs were observed entering decidual veins (Fig 
4A), as in the other decidua of similar age, suggesting that this aspect of the establishment of the 
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Interstitial mononuclear EVTs entered decidual lymphatics from W5.5-W12 
To exclude that the PECAM1-positive ACTA2-negative vessels were lymphatic vessels 
instead of veins, we investigated the expression of PDPN in the decidua [25-27]. Notably, 
not only PDPN-negative PECAM1-positive decidual veins were being invaded by interstitial 
mononuclear EVTs, but also many PDPN-positive PECAM1-positive decidual lymphatic 
vessels were in fact being invaded by interstitial mononuclear EVTs between W5.5-W12 (N=11 
out of 12 analyzed) (Fig 4B). We observed dilated PDPN-positive lymphatics encircling (or 
insulating) spiral arteries to create characteristic round structures (data not shown), confirming 
findings by Volchek and colleagues (2010) [27]. The biological significance of these characteristic 
structures remains to be investigated. We also report PDPN-positive mesenchymal stroma inside 
the placental villi (cyan arrow in S2 Fig, top right panel), as previously reported by Wang et al 
(2011) [28].
Aggregates of mononuclear EVTs were present in decidual veins from W5.5
At W5.5, we could already observe small aggregates of mononuclear EVTs in veins in the 
decidua basalis (Fig 5A). Those resembled syncytial knots, but were morphologically distinct. At 
later time points, from W7-W12 (N=6), bona fide syncytial knots (central area of multiple nuclei 
and large peripheral area of cytoplasm) were often present in dilated veins in both the decidua 
basalis (Fig 5A-B) and parietalis (Fig 5B), suggestive of the gradual establishment of materno-
placental vascular connection.
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Allo-epi-endothelium in the basal plate of first trimester decidua basalis
Finally, we report that the basal plate of the maternal decidua (between the anchoring 
villi) was lined by both (male) pKRT-positive EVTs and (female) PECAM1-positive maternal 
endothelial cells in the period analyzed (W5.5-W12) (Fig 6). This allo-epi-endothelium 
monolayer organization of ‘epithelial’ EVTs and maternal endothelial cells in a patchy-mosaic 
fashion has been described in term decidua [5] and we describe it now in the human decidua 
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DISCUSSION
Interstitial mononuclear EVTs enter the maternal circulation via veins and 
lymphatics
Our systematic analysis of first trimester decidua using a combination of 
immunofluorescence and FISH to distinguish between the types of vasculature and identify the 
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mononuclear EVTs of decidual veins and lymphatics in the maternal decidua basalis by W5.5. 
This suggests an efficient entry of interstitial mononuclear EVTs into the maternal (blood and 
lymph) circulation in the absence of robust materno-placental vascular connection [10-12]. 
Consistent with our findings, very recently the group of Huppertz has also showed 
evidence for EVTs invasion of uterine veins [29], using an antibody against human leukocyte 
antigen (HLA)-G, often used as specific EVT marker [30]. However, caution should be taken 
when using only HLA-G to identify EVTs, due to the different HLA-G isoforms [31]. In 
addition, using HLA-G immunostaining as means to identify EVTs, the same group has also 
reported that EVTs (coined “endoglandular”) also invaded uterine glands [32, 33]. In our study, 
using a combination of immunofluorescence and FISH, we were unable to detect (male) EVTs 
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The timing of the venous invasion process (by the EVTs) is different from the passive 
deportation of (non-viable) syncytial knots detaching directly from placental villi to the 
intervillous space and being then transported to the decidual venous lakes once the materno-
placental vascular connection has been established [13-15, 34]. 
Materno-fetal interface: EVTs stepping out of the uterus
The materno-fetal interface encompasses three main processes: the establishment of 
immune tolerance, regulation of decidual invasion by EVTs and uterine vascular remodeling 
[35], all taking place primarily in the uterus. Our results are in agreement with the timing of 
vascular remodeling as well as with the invasion of the decidua by interstitial and endovascular 
EVTs. Moreover, we observed the formation of the allo-epi-endothelium in the basal plate of the 
decidua basalis and therefore acknowledge the existence of epithelial EVTs [5].
Here, we propose that when interstitial mononuclear EVTs enter the maternal circulation 
they are not only substantially enlarging the materno-fetal interface, but they are also doing so 
earlier than previously accepted [via placental debris after materno-placental vascular connection 
[18]] and via an alternatively vascular route (decidual lymphatics and veins).
This novel venue of materno-fetal interface (taking place outside the uterus) may 
contribute significantly to trigger the maternal immune system to perhaps confer recognition 
to prevent rejection of the fetus while in the uterus. The EVTs have developed several strategies 
to ensure immune tolerance while in the maternal environment. This includes the expression of 
HLA-G, instead of HLA-A and HLA-B, in this way avoiding clearance by maternal natural killer 
cells [36]. In the uterus, the EVTs encounter and crosstalk with uterine macrophages, uterine 
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natural killer cells and T lymphocytes, modulating locally the maternal innate and adaptive 
immune response [35, 36]. The EVTs that enter the maternal circulation may have a primary 
role contributing to the adaptive and innate immune response, but through the recruitment of 
maternal cells to the uterus subsequently also contribute to successful vascular remodeling [4].
Materno-fetal interface and pregnancy complications
Sex chromosomal aneuploidy disorders, including Klinefelter syndrome, often produce 
small-for-gestational age fetuses [37]. We describe here the decidua basalis of one W8.4 pregnancy 
with Klinefelter syndrome (mosaic 47,XXY and 46,XY) and show interstitial mononuclear EVTs 
entering the maternal circulation via decidual veins. We were unable to detect “plugged” of 
remodeled arteries colonized by endovascular EVTs, probably due to the young age of the fetus. 
Our understanding of placental complications in humans is rather limited due to the lack 
of in vitro assays and suitable animal models. However it is clear that the materno-fetal interface 
in all its facets is indispensable for a successful pregnancy [38, 39]. We speculate that pregnancy 
complications such as preeclampsia and intrauterine growth restriction that are closely associated 
to defects in vascular remodeling [3, 7, 40], as well as recurrent abortion, may correlate with 
defective presence of EVTs in the maternal circulation.  
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S1 Table. Characteristics of the human decidua samples. 
Embryo ID Sex 
Age (weeks and 





EB3 XY W5.5 2 1 
EI1 XY W6.2 2 4 
EJ2 XY W7 2 4 
EM3 XY W7.2 1 1 
GP4 XY W7.2 1 - 
EL1 XY W7.5 1 - 
EC2 XY W8.1 2 1 
ED2 XXY W8.4 1 1 
FH1 XY W8.4 1 1 
GS1 XY W8.5 1 1 
EO3 XY W10 1 1 
FQ4 XY W10.6 1 3 
EG2 XY W12 3 2 
Total - - 19 20 
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ABSTRACT
Allele-specific DNA methylation is an important tool in studies of genomic imprinting. 
The IGF2/H19 imprinting control region (ICR1) is essential for normal fetal and placental 
growth and development. Its pattern of methylation during human early pregnancy is poorly 
understood. We aimed to search for possible non-CpG single nucleotide polymorphisms (SNPs) 
on ICR1 and to investigate the pattern of methylation of in different placental villi of first 
trimester human placenta and embryonic tissue using bisulfite DNA sequencing. We were able 
to select two informative non-CpG SNPs, rs2071094:G>T and rs2107425:C>T in two first-
trimester pregnancies, which allowed us to discriminate the paternal and maternal alleles. Our 
results indicate a normal imprint pattern in methylation of the IGF2/H19 ICR1in first trimester 
embryos and placental villi.
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INTRODUCTION
The imprinted IGF2/H19 cluster domain, controlled by the IGF2/H19 imprinting 
control region (ICR1), plays an essential role in growth and development of placental mammals 
[1, 2]. In humans, the IGF2/H19 ICR1, located on the 11p15.5 chromosomal region, controls 
the paternally expressed IGF2 and maternally expressed long non-coding RNA H19. One 
hypothesis for the regulation of this imprinting cluster is the insulator model for imprinting 
expression (reviewed in [3]), whereby the IGF2/H19 ICR1 unmethylated maternal allele allows 
the CCCTC-binding factor (CTCF) to bind to its (seven) insulator consensus sequences, whereas 
CTCF cannot bind to CTCF-binding sites in the methylated paternal allele. 
In humans, H19 has been reported to be biallelically expressed in cytotrophoblasts until 
10 weeks of gestation (W10), but to become monoallelically expressed in placenta at term, even 
though this could be due to the increased amount of mesodermal tissue in the placental villi [4-
7]. In agreement, term placentas seem to show a normal imprinted or slightly hypomethylated 
IGF2/H19 ICR1 [5, 8-11]. However, of those studies, only Turan and colleagues used informative 
single nucleotide polymorphisms (SNPs) (in that case rs10732516 present in the 6th CTCF 
binding site) to discriminate the parental origin of DNA methylation and reported not only 
variation between individual placentas but also pronounced spatial variation in the same term 
placenta [11].
Buckberry and colleagues compared the methylation status of the IGF2/H19 ICR1 
between term placentas and first-trimester placentas (W6-W12) and found no differences in 
average methylation levels in the 6th CTCF binding site (53.5%±7.2% versus 54.8%±6.9%, 
respectively) [5]. However, those authors used only one site of collection in the placentas and 
might have missed spatial variation in methylation. Moreover, although they discriminated 
allelic-specific expression, no discrimination was made between the parental alleles regarding 
the DNA methylation of the IGF2/H19 ICR1 and only global DNA methylation levels were 
reported. Villous cytotrophoblast proliferate and generate trophoblastic columns, from the tips 
of which extravillous trophoblast cells (EVTs) detach and invade the maternal decidua [12]. 
Here, we have investigated for the first time the spatial pattern of methylation of the IGF2/
H19 ICR1 in first-trimester placental villi, using informative SNPs to discriminate between the 
parental alleles. We report a normal imprinted pattern for IGF2/H19 ICR1 in all investigated 
placental villi samples, as well as in the respective embryos.
MATERIALS AND METHODS
Tissue samples and sex genotyping
The collection and use of the material for this study was approved by the Human Ethics 
Committee of the Leiden University Medical Center, Netherlands (P08.087). Informed consent 
was obtained on the basis of Helsinki Declaration by the World Medical Association (WMA). 
Tissues were collected from elective abortion of uncomplicated pregnancies, without medical 
indication. The embryonic tissue was sex genotyped as previously described, using polymerase 
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chain reaction (PCR) for AMELX/AMELY [13]. Endometrium and embryonic tissue from first 
trimester was used for genotyping analysis to identify informative SNPs in IGF2/H19 ICR1 
region. In addition, four intact placental villi from different parts of the same placenta (V1 to 
V4) were cut at the basal connection with the placental plate and individually stored at -80ºC 
for DNA methylation analysis. 
Detection of genomic SNPs in the IGF2/H19 ICR1 region
To identify genomic SNPs in the IGF2/H19 ICR1 region flanking the 6th binding site 
for CTCF (Table 1), genomic DNA of decidua and embryo was purified [14] and used for PCR 
(FW 5’-GTA TTT CTG GAG GCT TCT CCT TC-3’ and RV 5’-GAT CAT CAC ATA AGT 
AGG CGT GAC -3’) with conditions 95ºC 5 minutes, 35 cycles (95°C 30 seconds, 56ºC 30 
seconds, 72ºC 30 seconds), and 72ºC 5 minutes. The DNA fragments were sequenced by LGTC 
(www.lgtc.nl) and their sequence was aligned to identify SNPs (Table 1).
Bisulfite DNA sequencing
Genomic DNA from four different placental villi was modified and purified using 
the EpiTec Bisulfite Kit (Qiagen, Hilden, Germany) according to the manufacturer’s 
instructions. On bisulfite-treated DNA, PCR was performed using previously 
described bisulfite primers for the IGF2/H19 ICR1 region flanking the 6th binding 
site for CTCF [15] (FW 5’-TATGGGTATTTTTGGAGGTTTTTT-3’ and RV 
5’-AATCCCAAACCATAACACTAAAAC-3’), using AmplitaqTaq Gold DNA Polymerase 
(Applied Biosystems, CA, USA). PCR conditions were 95ºC 5 minutes, 50 cycles (94°C 45 
seconds, 59ºC 45 seconds, 72ºC 45 seconds) and 72ºC 10 minutes. The resulting amplicons 
were cloned using pENTR 5’-TOPO TA Cloning kit (Invitrogen, Carlsbad, CA) according 
to manufacturer’s instructions. The bacterial transformation was carried out in E. coli TOP10 
(Invitrogen, Carlsbad, CA). The obtained colonies were screened by PCR and positive clones 
were sequenced as above.
RESULTS 
We have investigated first the presence of informative genomic SNPs in the IGF2/H19 
ICR1 in six aborted pregnancies from first trimester (Table 1). Three SNPs (rs10732516:G>A, 
rs2071094:G>T, rs2107425:C>T) were heterozygous in Pregnancy 1 embryonic DNA 
and homozygous in corresponding maternal DNA (Table 1). Pregnancy 5 showed one SNP 
(rs2107425:C>T) to be heterozygous in embryonic DNA and homozygous in maternal DNA. 
However, the other four pregnancies (Pregnancies 2, 3, 4 and 6) showed same homozygous or 
heterozygous SNPs in both embryonic and maternal DNA. Therefore, only Pregnancies 1 and 5 
were included in further analysis. 
The IGF2/H19 ICR1 region analyzed contains 23 CpG sites (Fig 1). Interestingly, one of 
three identified informative genomic SNPs, rs10732516:G>A, is located on a CpG (CpG7 in 
Fig 1). For CpG7 (rs10732516) in Pregnancy 1, maternal alleles were AA (or TT in the reverse 
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strand) in DNA while embryonic alleles were AG (or TC). After bisulfite treatment, maternal T 
and methylated paternal C stay as T and C respectively, whereas unmethylated paternal C will be 
converted into T. Consequently, in bisulfite sequence of embryo, we could not tell whether the 
“T” in CpG7 is from maternal allele “T” or is from conversion of the unmethylated paternal allele 
“C”. Therefore, CpG7 was not taken into account in the analysis of methylation of IGF2/H19 
ICR1. We investigated the spatial pattern of methylation of the IGF2/H19 ICR1 in 4 different 
placental villi (and embryo) from Pregnancy 1. The density of methylation in the placental villi 
(excluding CpG7) was 124/147 (84.4%) in V1, 107/142 (75.4%) in V2, 128/149 (85.9%) in V3, 
108/112 (96.4%) in V4 and 68/86 (79.1%) in the embryo (Fig 1A). From the presence of two 
informative SNPs (rs2071094:G>T, rs2107425:C>T), the general hypermethylated pattern of 
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the maternal allele (rs2071094:T, rs2107425:C) was demethylated, whereas the paternal allele 
(rs2071094:G, rs2107425:T) was methylated. 
Next, we investigated the spatial pattern of methylation of the IGF2/H19 ICR1 in 4 
different placental villi (and embryo) in Pregnancy 5. The density of methylation in the placental 
villi (excluding CpG7) was 144/194 (74.2%) in V1, 116/164 (70.7%) in V2, 12/167 (7.8%) 
in V3, 146/166 (88.0%) in V4 and 194/217 (89.4%) in the embryo (Fig 1B). In each of the 
placental villi (and embryo) analyzed, the maternal allele (rs2107425:C) was demethylated, 
whereas the paternal allele (rs2107425:T) was methylated.
DISCUSSION
In humans, H19, but not IGF2, has been reported to be biallelically expressed at least in 
cytotrophoblasts before W10, but to become monoallelically expressed in placentas at term [4-6, 
16]. In agreement, several studies have reported that the IGF2/H19 ICR1 is normally imprinted, 
or slightly hypomethylated, in term placentas [5, 8-11, 17, 18]. However, of those studies only 
Turan and colleagues used a methylation sensitive restriction enzyme (MluI) in combination 
with the restriction enzyme CfoI (GCGC) to identify an informative SNP rs10732516 present in 
the 6th CTCF binding site, being able to identify allele-specific DNA methylation and reported 
a spatial variation in some term placentas [11]. In a recent study, Buckberry and colleagues 
compared the methylation status of the IGF2/H19 ICR1 between term placentas and first 
trimester placentas (W6-W12) and found no differences in mean methylation levels in the 6th 
CTCF binding site [5]. However, those authors used only one site of collection and although 
they discriminated between allele-specific expression, they were unable to discriminate between 
the parental alleles regarding the methylation of the IGF2/H19 ICR1, reporting only global 
DNA methylation levels.
Here, we have investigated for the first time the spatial pattern of methylation of the 
IGF2/H19 ICR1 in first-trimester placental villi of two pregnancies. In the placenta analyzed here, 
two non-CpG SNPs were informative for identification of allele-specific DNA methylation. The 
SNP rs2071094:G>T was previously described [2, 19] and a novel one, the SNP rs2107425:C>T 
which identified both paternal and maternal alleles, one methylated and the other unmethylated 
and therefore a normal imprint pattern in the IGF2/H19 ICR1 in the different placental villi and 
embryo, in contrast to some variability encountered between villi at term [11]. 
It is important to report a technical bias in bisulfite sequencing data towards 
hypermethylation that could have resulted from one allele being preferentially amplified or 
cloned over the other. Therefore, we suggest the combined use of the SNPs rs2071094:G>T 
and rs2107425:C>T as an important tool in allele-specific DNA methylation studies because it 
allows discrimination of both alleles and identifying a possible bias of bisulfite sequencing data 
for imprinting analysis.
The IGF2/H19 ICR1 is an important region that controls key genes for placental and 
embryo growth and development. The genomic imprinting in first trimester of pregnancies is 
95
IGF2/H19 imprinting pattern in human placenta | 
5
poorly understood and our results represent ongoing steps in understanding the role of epigenetic 
regulation during human gestation and the identification of a novel informative non-CpG SNP 
at IGF2/H19 ICR1, an essential feature for determining allele-specific DNA methylation. 
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SNPs Pregnancy 1 Pregnancy 2 Pregnancy 3 Pregnancy 4 Pregnancy 5 Pregnancy 6 
Embryo Mother Embryo Mother Embryo Mother Embryo Mother Embryo Mother Embryo Mother 
rs10732516: G>A* GA AA GG GG GG GG GA GA GA GA GA nd 
rs112620988: T>A TT TT TT TT TT TT TT TT TT TT TT nd 
rs34610866: G>- GG GG GG GG GG GG GG GG GG GG GG GG 
rs2071094: G>T GT TT GG GG GG GG GT GT GG GG GT GT 
rs35678657: G>T GG GG GG GG GG GG GG GG GG GG GG GG 
rs373018220: T>A TT TT TT TT TT TT TT TT TT TT TT TT 
rs113480908: G>A* GG GG GG GG GG GG GG GG GG GG GG GG 
rs56125822: C>T CC CC CC CC CC CC CC CC CC CC CC CC 
rs2107425: C>T CT CC TT TT CT CT CC CC CT CC CC CC 
rs76162918: C>A* CC CC CC CC CC CC CC CC CC CC CC CC 
   
Table 1. SNPs present in IGF2/H19 ICR1 and pregnancy genotypes.
*Informative SNPs present on a CpG; Bold, heterozygous SNP in embryo; Red bold, 
heterozygous SNP in embryo and homozygous in mother; nd, not determined.
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ABSTRACT
Genetic mouse model (39,XO) for human Turner syndrome (45,XO) harboring either a 
single maternally inherited (Xm) or paternally inherited (Xp) chromosome show a pronounced 
difference in survival rate at term. However, a detailed comparison of XmO and XpO placentas 
to explain this difference is lacking. We aimed to investigate the morphological and molecular 
differences between XmO and XpO term mouse placentas. We observed that XpO placentas at 
term contained a significantly larger area of glycogen cells (GCs) in their outer zone, compared 
to XmO, XX and XY placentas. In addition, the outer zone of XpO placentas showed higher 
expression levels of lactate dehydrogenase (Ldha) than XmO, XX and XY placentas, suggestive of 
increased anaerobic glycolysis. In the labyrinth, we detected significantly lower expression level 
of trophectoderm (TE)-marker keratin 19 (Krt19) in XpO placentas than in XX placentas. The 
expression of other TE-markers was comparable as well as the area of TE-derived cells between 
XO and wild-type labyrinths. XpO placentas exhibited specific defects in the amount of GCs 
and glucose metabolism in the outer zone, suggestive of increased anaerobic glycolysis, as a 
consequence of having inherited a single Xp chromosome. In conclusion, the XpO genotype 
results in a more severe placental phenotype at term, with distinct abnormalities regarding 
glucose metabolism in the outer zone.
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INTRODUCTION
Turner syndrome is the most common sex chromosome disorder affecting 1 in 2000 
live births. It is caused by the loss of genetic material from one of the sex chromosomes and the 
retained single X chromosome can be inherited either from the mother (Xm) or the father (Xp) 
[1]. In humans, 99% of the XO fetuses are lost during pregnancy [2, 3]. By contrast, in mice, 
90% of embryos with a single Xm survive to term, whereas 40% of embryos with a single Xp 
are resorbed due to severe placental abnormalities [4-6]. This suggests that the transcription of 
a single Xm or Xp in mouse placentas is not equivalent and influences development differently, 
reflecting either a different genome-wide epigenetic landscape between Xp and Xm or the 
existence of certain paternally imprinted X-linked genes in the mouse placenta.
X chromosome inactivation (XCI) is better understood in mice than in humans [7-11] 
due to the existence of well-studied genetic substrains of mice. In mice, in female (XX) late 
blastocysts, the trophectoderm (TE) and primitive endoderm (PE) show imprinted XCI (with 
an obligatory active Xm) and the epiblast (EPI) shows random XCI (in each cell either the Xm 
or Xp is active) [7, 10, 12]. In the placenta, the TE-derived cells [trophoblast giant cells (TGCs), 
spongiotrophoblasts and glycogen cells (GCs) in the outer zone; mononuclear trophoblast cells 
and syncytiotrophoblast cells in the labyrinth] maintain imprinted XCI (active Xm). By contrast, 
the chorionic plate and the embryonic endothelial cells of the labyrinth are derived from EPI, 
therefore showing random XCI. 
In humans, there may not be imprinted XCI in the placenta [13-15]. In agreement, by 
the end of the first trimester, the placental volume between XO and control placenta seemed 
comparable [16] and the birth weight of XmO and XpO new-born babies was similar [17]. 
Nevertheless, there is a higher incidence of XpO human fetuses lost during pregnancy [18] and 
the percentage of patients retaining the XmO is 60%-80% [19-23]. 
The placenta is a crucial organ during mammalian development, ensuring the selective 
and directional transport of gases, nutrients and waste products between the maternal blood and 
the embryonic blood [24]. In mice, the GCs may serve as a potential additional energy source, 
due to their high glycogen content and sensitivity to glucagon signaling [25]. The placenta is a 
highly regulative organ that adapts constantly to the maternal environment, for example oxygen 
tension and hypoxia [26, 27], availability of nutrients or calorie restriction [28] and exposure to 
maternal hormones [29, 30] to sustain optimal embryonic growth throughout pregnancy. 
Interestingly, (epi)genetic abnormalities that affect placental development trigger an 
adaptive response in the placenta to suppress the decreased efficiency to support embryonic 
growth [31-34]. In the case of XO embryos, embryonic day (E)8.5 XpO embryos had been 
shown to have small ectoplacental cones [35]. However, by E14, XpO placentas had caught up 
in size and some showed a larger outer zone [36]. At E18.5, XpO placentas were significantly 
heavier than XX controls [5]. But in a later study, XmO, XpO and XY placentas were found 
heavier than XX placentas [37]. 
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To date, a detailed comparison of XmO and XpO term placentas, in particular the TE-
derived part of the placenta, is missing. Here, we show that E18.5 XpO placentas exhibited 
significantly larger area occupied by GCs in outer zone when compared to XmO, XX and XY 
placentas. Moreover, the expression of Ldha, coding for the enzyme that converts lactate to 
pyruvate through anaerobic glycolysis, was significantly higher in outer zone of XpO placentas 
than the XmO, XX and XY placentas, suggesting increased anaerobic glycolysis and underlying 
possible defects in oxygen availability in XpO placentas. In conclusion, the XpO genotype results 
in a more severe placental phenotype at term, with distinct abnormalities regarding glucose 
metabolism in the outer zone.
MATERIALS AND METHODS
Mice and genotyping
All animal tissues used in this work were a generous gift from P. Burgoyne in accordance 
with the United Kingdom Animals Scientific Procedures Act 1986 and approved by the local 
ethical committee of the National Institute of Medical Research, London. MF1 mice bearing 
XX and XY embryos were from XX x XY crossings. XmO and XpO mice were generated as 
previously described [37]. Briefly, XmO animals were produced by crossing XX females with 
XYO males, and identified by visual detection of female genitalia; the XYO males were generated 
by crossing XPafO females with XY* males. The XpO animals were generated by crossing In(X)
Paf/X females with XY males. All females (In(X)/X, XXPaf and XpO) were karyotyped with 
trypsin-Giemsa banding using fresh liver to identify the XpO embryos (with 39 chromosomes 
as opposed to 40 chromosomes).
Placenta collection and histology
From a total of 12 litters, E18.5 embryos were isolated in phosphate buffer saline (PBS) 
and separated into males and females by morphology and genotyped as above. The placentas 
were dissected into quarters and some quarters were collected for RNA isolation after removal 
of the outer zone (Jz, TGCs and decidua), whereas others were fixed in 4% paraformaldehyde 
(PFA, Merck, Darmstadt, Germany) at 4°C overnight (o/n), washed in PBS and dehydrated 
through increasing concentrations of ethanol and finally xylene, embedded in paraffin and 
serially sectioned (5 μm) in the sagittal plane using a microtome (Leica RM2055, Nussloch, 
Germany) in the medial-to-lateral direction (N=3 XX, N=3 XY, N=5 XmO, N=4 XpO).
Prior to Periodic acid-Shiff (PAS) staining, sections were deparaffinised in xylene, 
rehydrated through a series of ethanol solutions and incubated 30 minutes at 56°C in pre-heated 
1% periodic acid (Sigma-Aldrich, St. Louis, USA), rinsed in water, immersed in Schiff’s reagent 
(Klinipath, Duiven, The Netherlands) 30 minutes at room temperature (RT), rinsed in water 
and counterstained with Mayer’s haematoxylin (Merck, Darmstadt, Germany). Congo red, 
Masson’s trichrome and Hematoxylin-eosin staining were performed using standard histological 
procedures. Stained sections were washed in water, dehydrated through a series of ethanol, xylene 
and mounted in Entellan (Merck, Darmstadt, Germany).
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Quantitative reverse-transcription polymerase chain reaction (QPCR)
QPCR was performed on placental quarters after removal of the outer zone and analyzed 
as described [38]; or on RNA material isolated from 5x paraffin sections of the outer zone using 
RecoverAll total nucleic acid isolation kit (AM1975, Ambion, Carlsbad, CA, USA) following 
the manufacturer’s protocol. For normalization, the ΔΔCt method was used with the reference 
genes Ubc and B2m, stably expressed in mouse placenta [39]. All individual placentas were 
analysed in technical triplicates. The fold change in expression was calculated relative to the XX1 
placenta. Briefly, the average ΔCt value from the technical triplicates of the XX1 (Ave ΔCt XX1) 
was calculated. Next, we subtracted Ave ΔCt XX1 from each ΔCt (ΔΔCt) and the relative fold 
change (2^-(ΔΔCt)) calculated. The fold change of each of the triplicate values per placenta was 
then averaged (mean) and the standard deviation was calculated. The primers used are listed in 
S1 Table.
Immunofluorescence
Paraffin sections were deparaffinised and used for immunofluorescence as previously 
described [40]. Primary antibodies used were rabbit anti-KRT19 (or keratin 19) (1:250; ab52625, 
Abcam, Cambridge, UK) and rat anti-EMCN (or endomucin) (1:150; sc-65495, Santa Cruz 
Biotechnology, Santa Cruz, CA, USA). Afterwards, sections were washed in 0.05% Tween-20/
PBS, treated with 0.3% Sudan Black B (Edward Gurr Ltd, London, UK) in 70% ethanol for 5 
minutes to eliminate background autofluorescence from red blood cells [41] and incubated with 
secondary antibodies diluted in blocking solution for 1 hour at RT. Secondary antibodies were 
Alexa Fluor 488 goat anti-rabbit (1:500; A-11034, Life Technologies, Eugene, OR, USA) and 
Alexa Fluor 555 goat anti-rat (1:500; A-21434, Life Technologies, Eugene, OR, USA). Nuclei 
were stained with 4',6-diamidino-2-phenylindole (DAPI) (Vector Laboratories, Peterborough, 
UK) and sections were mounted in Prolong Gold anti-fade reagent (Life technologies, Eugene, 
OR, USA). Slides used for isotype controls were treated as above using rabbit immunoglobulin 
fraction (1:250; X0903, Dako, Heverlee, Belgium) and rat IgG2a (1:150, MAB006, R&D 
Systems, Minneapolis, MN, USA) instead of the primary antibodies.
Imaging and quantification
Bright-field images were taken on an Olympus AX70 microscope (Olympus, Zoeterwoude, 
Netherlands) equipped with a digital camera (Olympus XC50, Tokyo, Japan). Fluorescence 
images were acquired on a Leica DMRA fluorescence microscope (Leica, Wetzlar, Germany) 
with a CoolSnap HQ2 camera (Photometrics, Tucson, USA) or a Leica AF6000 fluorescence 
microscope with a Hamamatsu EM-CCD C9100 camera (Leica Microsystems, Wetzlar, 
Germany). Quantification was performed in ImageJ 1.48 (http://imagej.nih.gov/ij). 
Statistical analysis
The statistical analyses of the proportion of glycogen cells area in the outer zone of the 
placentas, the percentage of fetal vascular space, the area occupied by TE-derived cells in the 
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labyrinth and differential gene expression per genotype were performed using one-way ANOVA 
with the Tukey-HSD applied for post hoc testing, using statistical software package SPSS 20.0 
(SPSS Inc., Chicago, IL, USA). P<0.05 was considered significant. 
RESULTS
At term, XpO placentas showed larger area occupied by GCs in the outer 
zone
We investigated the placental morphology of the four genotypes (N=3 XX, N=3 XY, N=5 
XmO, N=3 XpO) at E18.5 using PAS-staining. This allowed us to distinguish the outer zone 
from the labyrinth (Fig 1A). We observed the presence of a broader outer zone in the lateral part 
of XmO (N=2 in 5, 40%) and XpO (N=3 in 3, 100%) placentas (Fig 1A). To quantify the area 
occupied by GCs in the outer zone, the ratio of the area occupied by GCs in the outer zone was 
calculated on individual placental sections (n=3-5 medial sections per placenta, containing a 
visible connection to the umbilical cord) (Fig 1B-C). The XpO placentas contained a significantly 
larger area occupied by GCs in the outer zone when compared to XX, XY and XmO placentas 
(P=0.004, 0.008 and 0.045 respectively, Fig 1C). In contrast, the area occupied by GCs in the 
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At term, XpO placentas showed increased Ldha expression in the outer zone 
The larger area of GCs in outer zone of XpO placentas led us to investigate defects in 
gene expression related to glucagon signaling and glucose metabolism (Fig 2A) in the outer zone. 
The expression level of glucagon receptor (Gcgr) as well as of glucose transporter Slc2a1, which 
mediate passive glucose uptake in cells [42] was similar between XmO, XpO and XX placentas 
(Fig 2B, S2 Table). 
Two X-linked genes, G6pdx and Pgk1, encode essential enzymes in the conversion of 
glucose to pyruvate [43, 44]. In the outer zone, G6pdx showed significantly lower expression in 
both XmO and XpO placentas compared to the XX placentas (XmO versus XX: P=0.028; XpO 
versus XX: P=0.007; Fig 2B, S2 Table). However, expression of Pgk1 was significantly higher in 
XpO placentas than in XmO placentas (P=0.009, Fig 2B, S2 Table). 
Under normal oxygen supply (aerobic glycolysis), pyruvate is catabolized into acetyl-
CoA to be used in the tricarboxylic acid (TCA) cycle to produce energy efficiently (Fig 2A). 
One of the enzymes of the TCA cycle, encoded by X-linked gene Idh3g, showed similar 
expression between XO and wild-type placentas (Fig 2B, S2 Table). However, if oxygen supply 
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enzyme that converts pyruvate into lactate is encoded by the Ldha gene. The expression levels 
of Ldha in the outer zone of XpO placentas were significantly higher than in the other placentas 
(XpO versus XX: P=0.007; XpO versus XY: P=0.015; XpO versus XmO: P<0.001; Fig 2B, S2 
Table), suggesting higher levels of anaerobic respiration specifically in the outer zone of the XpO 
placentas, where a higher incidence of GCs was found.
The labyrinths of XO and wild-type placentas were comparable
Next, we determined the relative expression of TE markers [keratin 19 (Krt19), syncytin b 
(Synb), glial cells missing homolog 1 (Gcm1)] and endothelial markers [endoglin (Eng), platelet/
endothelial cell adhesion molecule 1 (Pecam1)] in the labyrinth of the four types of placentas. 
The expression levels of TE-marker Krt19 in the labyrinth of XpO placenta were 
significantly lower than that in XX placenta (P=0.024, Fig 2C, S2 Table). However, the TE-
markers Synb and Gcm1 were similarly expressed in the four types of placentas (Fig 2C, S2 Table). 
There was also no difference in the expression of endothelial-markers Eng and Pecam1 in the 
labyrinth (Fig 2C, S2 Table). Together, the data suggests that the labyrinth of XO placentas may 
be similar to wild-type placentas. 
To further confirm that, we quantified the area occupied by (EMCN-positive) fetal 
capillaries and (KRT19-positive) TE-derived cells in the labyrinth (n=3-5 sections per individual 
placenta; N=3 XX, N=3 XY, N=5 XmO, N=4 XpO) (Fig 3). For the quantification, single 
channel images of the labyrinth zone from medial placental sections immunostained for anti-
EMCN (red) and anti-KRT19 (green) and DAPI (details shown in Fig 3B,D,E) were used. The 
area of the fetal vasculature (Fig 3B), considered the area occupied by the EMCN-positive fetal 
capillaries, was similar between XO and wild-type labyrinths (Fig 3C, left panel). Moreover, the 
vascular density, calculated as the number of fetal capillaries per image, was also comparable 
between XO and wild-type labyrinths (Fig 3C, right panel). 
To quantify the area of occupied by TE-derived cells, the nuclei area (DAPI-positive) 
was merged with the KRT19-positive cytoplasmic staining of the TE derived cells. However, to 
exclude the nuclear area of the fetal vasculature, we subtracted the fetal vascular area (Fig 3B,D,E). 
In this way, we obtained the area occupied solely by TE-derived cells (cytoplasm and nuclei). We 
concluded that the area occupied by TE-derived cells in labyrinth was similar between XO and 
wild-type placentas (Fig 3E). 
At term, XpO placentas showed decreased Xlr4b/4c in the labyrinth zone 
The X-linked Xlr3b has previously been identified as differentially expressed in XmO and 
XpO brains, but not in the placentas [45]. In addition to Xlr3b, Xlr4b/4c were also reported to 
be differentially expressed between XmO and XpO brains, but at least Xlr4c not in placentas [46]. 
However, whole placentas were used for analysis and a possible regional regulation could have 
been missed. We therefore investigated the expression of Xlr3b and Xlr4b/4c separately in outer 
zone and labyrinth zone of term placenta.
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We did not observe significantly differential expression of Xlr3b and Xlr4b/4c in the XpO 
and XmO outer zones (Fig 4A, S2 Table), even though XpO outer zones had significantly lower 
Xlr3b than XY outer zones (P=0.030; Fig 4A, S2 Table). In the labyrinth zone, the expression 
levels of Xlr3b were comparable between genotypes (Fig 4B, S2 Table), but surprisingly XpO 
labyrinth zone had significantly lower expression levels of Xlr4b/4c than the other placentas 
(XpO versus XX: P=0.006; XpO versus XY: P<0.001; XpO versus XmO: P=0.003; Fig 4B, S2 
Table). 
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At term, XmO placentas contained higher incidence of fibrin nodules in the 
maternal arterial sinuses adjacent to the chorionic plate
Interestingly, the XmO placentas contained small nodules, partially occluding some 
maternal arterial sinuses proximal of the chorionic plate (black arrow in Fig 1A). After Congo 
red, Masson’s trichrome and Hematoxylin-eosin staining, we concluded that those were fibrin 
deposits (Fig 5A).
 To quantify the incidence of fibrin nodules in the different placentas (N=3 XX, N=3 XY, 
N=5 XmO, N=4 XpO), we manually counted the number of fibrin nodules present in medial 
placental sections. All XmO placentas contain fibrin deposits in most sections analyzed, whereas 
the nodules were not observed in most of the other placentas (XmO versus XX: P=0.0007; XmO 
versus XY: P=0.0007; XmO versus XpO: P=0.0019; Fig 5B). On average, per section one or two 
nodules were observed (Fig 5A,C).  
DISCUSSION
The lack of a second sex chromosome in XO mouse embryos leads to the development of 
smaller trophectoderm ectoplacental cones and, in some cases, pregnancy loss [5, 6, 35, 37, 47]. 
Our study on XO placental abnormalities in mice shows that inheriting the single X chromosome 
from the paternal or maternal side leads to different placental phenotypes: E18.5 XpO placentas 
contained a larger area of GCs in the outer zone with a possible consequent increase in anaerobic 
glycolysis and/or oxygen availability. This does not seem to be the case in XmO placentas. By 
contrast, XmO placentas show increased incidence of small fibrin nodules in maternal arterial 
sinuses proximal of the chorionic plate.
The placenta is sensitive to defects in epigenetic regulation, such as regulation of imprinted 
genes and imprinted X inactivation [31-33]. As such, it is not surprising that many imprinted 
and X-linked genes are expressed in the placenta and regulate metabolism and growth [31, 33, 













of the outer zone of the placenta [31, 33, 34]. The higher incidence of GCs in the outer zone 
of XpO placentas may be such an adaptive response to placental insufficiency. Studies in mice 
show that XpO fetuses have a higher risk of being lost during pregnancy, whereas XmO fetuses 
generally have a better chance of surviving to term [6, 35]. In XX fetuses, the Xp is preferentially 
inactivated in the TE-derived tissues [48]. Thus, in both females and males, it is the Xm that 
is active in TE-derived tissues during placental development. Epigenetic differences between 
Xp and Xm, including genome-wide differences in chromatin condensation or the existence of 
X-linked paternally imprinted genes in the placenta, could explain why XpO embryos have a 
higher risk of being lost during pregnancy.
Alternatively, as a smaller trophectoderm ectoplacental cone in XO embryos is often 
associated with a delay in embryonic development [35, 37, 47], the alteration observed in GCs 
in outer zone of XpO placentas could reflect a general small delay in development instead of an 
(active) adaptive response. Interestingly, it has been shown that both the number of GCs and the 
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volume of the junctional zone increases during gestation, peaks at E16.5, followed by reduction 
until birth [25, 49]. Therefore, if the physiological regression of GCs in XpO placentas was 
delayed, this would result in relatively more GCs and increased size of the outer zone at E18.5 
compared to wild-type placentas.
Abnormal GC numbers, related to impaired glucose transport and glycogen metabolism 
in placenta [50, 51], have been reported in several mutant mouse placentas, including that of 
X-linked and imprinted genes, and usually result in runting. Opposite phenotypes regarding 
GCs numbers can still develop in mouse mutants showing a normal placenta at E10.5. As the 
XpO phenotype, maternally inherited defects in X-linked Evx1 also showed higher numbers of 
GCs, spongiotrophoblasts and secondary TGCs by E14.5 and the mutant pups were smaller 
at birth [52]. By contrast, Cited2 KO and the imprinted (paternally-expressed) Igf2 KO mice 
show severe reduction of numbers of GCs, spongiotrophoblasts and secondary TGCs at E12.5-
13.5 [53, 54], but this also resulted in reduced weight at birth [51]; whereas the imprinted 
(maternally-expressed) Cdkn1c (or p57Kip2) KO showed placentomegaly, with larger labyrinth 
zone and excess of spongiotrophoblasts, but normal number of GCs and TGCs and no difference 
in the weight of embryos [55].
It is unclear whether Xlr factors are directly involved in glucose metabolism, but they 
could impact on cell differentiation in the outer zone towards GC cells. We observed similar 
expression of Xlr3b and Xlr4b/4c in XpO and XmO outer zones suggesting that these genes 
are not involved in the production of GCs and are not imprinted in the (TE-derived) outer 
zone. However, the biological significance of the specific decrease in Xlr4b/4c in XpO labyrinth 
remains to be investigated. If this decrease is not due to imprinting in TE-derived labyrinth 
cells (mononuclear trophoblast and syncytiotrophoblast cells), then perhaps Xlr4b/4c could be 
imprinted and silenced on the Xp in the EPI-derived endothelial cells of the labyrinth, in line 
with the reported imprint in the brain (Raefski and O’Neill, 2005). This could explain the 40% 
reduction in expression observed.
Small fibrin nodules, most probably from maternal blood-clots, were observed in the 
maternal sinus of all XmO placentas, but not in most of the other placentas. Interestingly, TE-
derived cells at the fetal-maternal interface in both mouse and human exhibit endothelial-like 
properties (endovascular extravillous trophoblast cells and syncytiotrophoblast cells in humans; 
syncytiotrophoblast cells in mice) and seem to be involved in the regulation of coagulation during 
pregnancy [56]. Fibrin deposits are occasionally described in the labyrinth and spongiotrophoblast 
area of mouse placentas [57, 58]; and in the perivillous space, associated with local syncytial 
denudation, in human placentas [59, 60]. Excessive fibrin deposits at the fetal-maternal interface 
early during development, such as in Procr (or Epcr) KO embryos results in severe placental 
thrombosis and lethality at E10.5 [61]; whereas in Wnt2 KO embryos showed fibrin deposits 
between E14-18 with maternal blood accumulation in the labyrinth zone, resulting in 50% 
viability and smaller pups at birth [62]. The fibrin deposits in XmO placentas indicate excessive 
activation of the coagulation cascade in the maternal circulation, but this obstruction was not as 
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severe as in Wnt2 KO mice and, as such, does not seem to be pathological. 
In conclusion, mouse embryos with a single Xp have a lower chance than XmO embryos 
to survive to term due to placental insufficiency. Here, we show that XmO and XpO term 
placentas differ significantly in the amount of GCs in the outer zone and that XpO placentas may 
have shifted towards anaerobic glycolysis. This shift in glucose metabolism does not seem to be a 
direct consequence of altered expression of X-linked genes involved in this metabolism (although 
Pgk1 expression differs between XmO and XpO outer zones), but rather a consequence of an 
altered cellular composition of the XpO outer zone (large GCs area) due to placental adaptive 
response earlier during development. Our findings highlight the need to investigate glucose 
metabolism in the placenta of human Turner patients, which may provide individual potential 
therapeutic strategies for Turner syndrome.  
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HUMAN (EXTRA)GONADAL GERM CELL DEVELOPMENT
From the extragonadal location in which they originate, human primordial germ cells 
(PGCs) migrate and arrive at the developing gonadal primordia at approximately week 7 of 
gestation (W7, or week 5 post conception) [1-3]. Ectopic PGCs have been described in mouse 
and bovine adrenals [4-6]. Mostly, these ectopic germ cells are eliminated by apoptosis [7, 8]. 
However, some of them may escape from entering the normal apoptosis pathway and give rise 
to extragonadal germ cell tumors [9, 10]. Since the gonads have a common somatic origin as 
adrenal cortex [11-13], the aim of Chapter 2 is to investigate whether there are human ectopic 
germ cells in adrenals and to study the development of human (extra)gonad germ cells in first 
and second trimesters. 
Human germ cells (POU5F1-positive and/or DDX4-positive) are present in all 
W8.4-W22 adrenal glands, but not in kidney. Between first and second trimesters, germ cells 
gradually downregulate the pluripotency marker POU5F1 and upregulate late germ cell marker 
DDX4 in both male and female gonads. Human ovarian germ cells do not enter meiosis 
synchronously at W22, in agreement with previous reports [3, 14, 15]. Meiotic entry of mouse 
adrenal and gonadal PGCs has been described to be synchronous [6]. In contrast to mice, human 
adrenal germ cells show no meiotic entry at least until W21.5, although the possibility that they 
enter meiosis afterwards cannot be excluded. This work serves as a reference presenting evidence 
for the existence of human ectopic germ cells in adrenals. Our findings highlight differences in 
gonadal and extragonadal gametogenesis between humans and mice. 
Human PGCs have been suggested to migrate along class III beta-tubulin (TUBB3)-
positive neural crest derivations to reach gonadal primordia [2, 10]. Interestingly, early germ 
cells (POU5F1-positive) in gonads and adrenals are also TUBB3-positive whereas late germ 
cells (DDX4-positive) are TUBB3-negative. The PGCs that migrate along common routes with 
neural crest cells to reach the adrenal may thus become ectopic germ cells there. Because the 
gonads have a common somatic origin as adrenals [11-13], rat PGCs are shown to reach adrenals 
before gonadal and adrenal primordia are physically separated [16]. This can also explain the 
colonization of human ectopic germ cells in adrenals. Furthermore, it is important to study the 
fate of these ectopic germ cells during further development. Whether they will enter meiosis or 
will lose their germ cell identities?
Ectopic PGCs that escape from entering apoptosis are thought to account for the 
development of extragonadal germ cell tumors [9, 10, 17, 18]. Interestingly, single-nucleotide 
polymorphisms (SNPs) located in gene DDX4 have been found to be associated with 
neuroblastoma tumors [19]. Furthermore, TUBB3-positive neural crest derivatives are thought 
to be related to the origin of adrenal neuroblastoma tumors [20]. Since there is expression of 
TUBB3 in ovarian and adrenal POU5F1-positive germ cells, further studies are needed to 
investigate the potential relationship between ectopic adrenal germ cells and neuroblastoma by 
studying the expression of additional markers.
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EPIGENETIC REGULATION IN HUMAN PRE-IMPLANTATION EMBRYOS AND 
FIRST-TRIMESTER PLACENTAL VILLI
X chromosome inactivation (XCI) and genomic imprinting are two essential specific 
epigenetic regulation processes established in early development [21], controlling the dosage of 
X-linked genes and parent-of-origin-specific genes respectively. 
Well-studied genetic substrains of mice have revealed two separate XCI waves during 
mouse female embryo development [22, 23]. However, the XCI dynamics in human female 
pre-implantation embryos remain unknown, because the parental allelic origin of human 
embryos is often not available. Recent advances (i.e. single cell RNA-Seq) have enabled the 
allele-specific expression analysis in human pre-implantation embryos to study XCI status at 
single-cell resolution [24]. The main aim of Chapter 3 is to understand the status of XCI in 
human pre-implantation embryos at single-cell level. Do trophectoderm (TE) cells have different 
XCI pattern from inner cell mass (ICM) at embryonic day (E)5-E7? If there is X inactivation, 
whether the XCI pattern is imprinted or random? In this study, X-linked genes are separated 
into X-sub (X-genes subject to X inactivation) and X-esc (escapees) categories since escapees have 
biallelic expression, even though some studies do not show significant differences in escapees 
expression level between sexes [25, 26]. As demonstrated in Chapter 3, equal proportion of 
biallelic expression in X-sub and in autosomal genes suggests that both X chromosomes are 
active in E3 cells. A smaller proportion of biallelic expression in X-sub than in autosomal genes 
indicates that one X chromosome is inactive in E4-E6 cells and E7 TE cells, whereas there is 
reactivation in E7 epiblast (EPI) and primitive endoderm (PE) cells. Additionally, equal DNA 
methylation of both maternal and paternal alleles in AR and RP2 genes indicates non-imprinted 
X inactivation in human TE-derived cells, in contrast to the imprinted XCI in mouse TE cells 
[22]. Results strongly contrast with the previous hypothesis that both X chromosomes are 
active during human pre-implantation (E3-E7) development [24]. This is because in the allele-
specific expression analysis of Petropoulos and colleagues [24], without genome sequencing data, 
only the SNPs with biallelic expression or random monoallelic expression could be detected as 
informative SNPs. Therefore, SNPs having imprinted monoallelic expression within an embryo 
would be missed in the analysis. In addition, those genes with biallelic expression can be X-esc 
genes at human pre-implantation stage. In another study using RNA FISH for X-linked genes to 
detect XCI, ATRX gene shows biallelic expression in most cells of E5 female blastocysts (without 
separation of ICM from TE) [27]; however, ATRX gene is an X-Y paired gene (thus an escapee) 
[28] which is supposed to have biallelic expression even on the inactive X chromosome. The first 
XCI wave in mouse pre-implantation embryos occurs at the two- to four-cell stage [23] while 
in humans it happens between E3-E4. This difference is probably due to the different timing of 
zygotic genome activation (ZGA) in mice (at two-cell stage [23]) and in humans (at E4 [24, 29]). 
The imprinted IGF2/H19 cluster domain, controlled by the IGF2/H19 imprinting 
control region (ICR1), plays an essential role in placental and embryo growth and development 
in mammals [30, 31]. According to the parent-offspring conflict theory [32], paternally expressed 
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IGF2 gene enhances cell proliferation while maternally expressed H19 gene inhibits embryo 
growth and somehow negatively affects size of the offspring [33]. Gain or loss of methylation at 
ICR1 and consequent dysregulation of IGF2/H19 account for perinatal complications including 
small for gestational age embryos, intrauterine growth restriction, Beckwith–Wiedemann 
syndrome (BWS) [34] and Russell–Silver syndrome (RSS) [35]. Chorionic villus sampling (CVS) 
is a procedure used in prenatal diagnosis of fetal abnormalities. However, it remains unknown 
whether spatial variation in methylation exists in placental villi and whether the imprinting 
pattern in placental villi is representative for the fetus. Therefore, the focus of Chapter 5 is to 
investigate whether the multiple sites of first-trimester placental villi show the same imprinting 
pattern of IGF2/H19 and whether it is the same as in the embryo. In the multiple sites of 
collection in human first-trimester placental villi (and embryos) analyzed in two pregnancies, 
demethylated maternal alleles and methylated paternal alleles indicate that multi-site placental 
villi collections have the same imprinting pattern of the IGF2/H19 ICR1, also being the same as 
in embryos. This contrasts with the variability reported between different placental villi at term 
[36]. The difference may be resulted from the fact that Turan et al analyzed a larger number of 
placentas, but only one CpG point was analyzed, whereas in our study the methylation status 
of all CpGs in two placentas are investigated by bisulfite sequencing. In humans, H19, but not 
IGF2, has been reported to be biallelically expressed at least in cytotrophoblasts before W10, but 
to become monoallelically expressed in placentas at term [37-40]. Since there is a mixture of two 
cell types within placental villi (TE-derived trophoblast cells and ICM-derived mesenchymal 
cells), it remains to be investigated whether the imprinting patterns of IGF2/H19 ICR1 in these 
two cell types are the same as in the embryo. 
The epigenome is known to be sensitive to environmental changes [41]. Studies have 
suggested that treatments and procedures (i.e. ovarian stimulation, intracytoplasmic sperm 
injection, pre-implantation embryo culture) in assisted reproductive technology (ART) may 
change epigenetic marks (including IGF2/H19) of gametes and embryos [42-46]. Moreover, 
children conceived by ART are reported to have a higher incidence of imprinted disorders 
(i.e. Angelman syndrome and BWS) [47-49]. Therefore, the epigenetic dynamics during pre-
implantation development is expected to be better understood within the next decades, which 
shall provide evidence for embryo selection [via pre-implantation genetic diagnosis/screening 
(PGD/PGS)] and successful pregnancy in assisted reproduction. Although obtaining maternal 
and/or paternal materials has of course both ethical and practical issues, future work investigating 
(epi)genetics in human pre-implantation embryos may require embryonic genome sequencing, 
embryonic RNA-Seq as well as parental genome sequencing data. Furthermore, future 
investigations could extend to XCI dynamics and imprinting pattern in TE-derived trophoblast 
cells and ICM-derived mesenchymal cells in placental villi. 
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HUMAN EXTRAVILLOUS TROPHOBLAST CELLS (EVTS) INVASION IN 
DECIDUAL VASCULATURE DURING EARLY PREGNANCY
Fetal EVTs have been described to block the entrance of uterine spiral arteries at W8-W12, 
thus preventing maternal blood flow into the intervillous space [50-52]. However, exosomes, 
placental particles [53, 54] and fetal cells [55] have been detected in the maternal blood from W6 
onwards, without the presence of robust materno-placental vascular connection. For this reason, 
the aim of Chapter 4 is to investigate whether there are alternative routes for EVTs to enter 
maternal circulation in early pregnancy (W5.5-W12) other than via spiral arteries. As shown 
in Chapter 4, fetal mononuclear EVTs enter veins and lymphatic vessels in decidua basalis 
directly from W5.5 onwards, much earlier than their remodelling decidual spiral arteries at W8. 
Same observation in a pregnancy with Klinefelter syndrome in the conceptus (W8.4, mosaic 
46,XY and 47,XXY) indicates that efficient entry of maternal (blood and lymph) circulation by 
interstitial mononuclear EVTs occurs much earlier than previously reported W8 (via entering 
spiral arteries) [53]. These findings are supported by two very recent studies showing EVTs 
invasion in decidual veins in the first trimester, based on immunofluorescence for the EVT 
marker HLA-G [56, 57]. While attention should be paid to the different HLA-G isoforms when 
using HLA-G to determine EVTs [58], we are the first to combine chrX/chrY fluorescence in 
situ hybridization (FISH) and immunofluorescence to address the problem for unambiguous 
(male) EVTs identification. It could be important to investigate the EVTs invasion in decidua in 
pregnancies with other sex chromosomal disorders (i.e. Turner syndrome).
The entry of maternal circulation by EVTs via decidual veins and lymphatics since W5.5, 
occurring much earlier than the establishment of maternal-placental vascular connection at 
W8-W12 [53], enlarges the maternal-fetal interface during early pregnancy. Therefore, while 
maternal immune response in the uterus include crosstalk between immune cells (natural killer 
cells, lymphocytes) and EVTs [59, 60], EVTs invading maternal circulation contribute to the 
response that takes place outside the uterus. 
Insufficient invasion of human fetal EVTs into maternal decidua may cause inadequate 
placental perfusion and consequent pregnancy complications including preeclampsia and 
intrauterine growth restriction [61-64]. Using the approach provided in Chapter 4 to identify 
the (male) EVTs unambiguously in maternal decidua, defective EVTs invasion in pregnancy 
complications can be further defined and this may lead to identification of underlying mechanism 
and promising therapy strategies. 
Question remaining to be answered is the underlying cellular/molecular mechanism 
of EVTs invasion in vein and lymphatics in first trimester. Other investigations could focus 
on the shared invasive characteristics (epithelial–mesenchymal transition) between EVTs and 
metastasizing malignant cells [65]. This may offer more knowledge on causes of tumor metastasis 
and provide valuable tumor therapies. 
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ABNORMALITIES IN MOUSE TURNER SYNDROME PLACENTAS
Mice with a genetic form of Turner syndrome (39,XO) harboring either a single paternally 
inherited (Xp) or maternally inherited (Xm) chromosome show quite different survival rates to 
term [66-68]. Nevertheless, no detailed comparison of XpO and XmO placentas has been made 
to explain this difference. The aim of Chapter 6 is to study whether the transcriptional level 
of Xp is equal to Xm, by comparing the consequences of Turner syndrome harboring either a 
single Xp or Xm in mouse E18.5 placenta. The larger area occupied by glycogen cells (GCs) and 
significantly increased expression level of Ldha in the outer zone (junctional zone, trophoblast 
giant cells and decidua) of XpO placenta indicate that the XpO genotype leads to a more severe 
placental phenotype than XmO at E18.5, and thus the transcriptional level of Xp is not equal 
to Xm.
During placental development, TE-derived cells in XX placentas have obligatory active 
Xm and inactive Xp [69]. The significantly larger amount of GCs in the XpO outer zone 
might be an adaptive response to defects in the epigenetic regulation of imprinted genes [70-
72]. Moreover, abnormal amount of GCs, serving as a potential source of energy in mouse 
placenta [73], may indicate defects in glycogen metabolism and glucose transport [74, 75]. The 
higher Ldha expression, which encodes the enzyme converting lactate to pyruvate in anaerobic 
glycolysis, suggests increased anaerobic glycolysis and possible insufficient available oxygen in 
XpO placentas. This is in accordance with the reported increase in Ldha expression in human 
primary placental trophoblast cells cultured under hypoxic conditions [76]. 
Although it remains to be clarified how harboring either a single Xp or Xm affects mouse 
placental development and function, findings in Chapter 6 contribute to the understanding of 
different effects of inheriting a single paternal or maternal X chromosome on mouse placental 
phenotypes and hints to a defect in glucose metabolism. The investigation of glucose metabolism 
in human Turner syndrome patients and their placentas is needed and may provide new 
therapeutic strategies for individuals.
Together, the results in this thesis provide new insights into normal development of 
human (extra)gonadal germ cells, human pre-implantation development as well as placental 
development in humans and mice. Furthermore, results offer more knowledge on how defects in 
these processes might cause abnormal pregnancy outcomes and placental functions. 
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Studies aimed at understanding pre-implantation and placental development in 
humans and mice have provided essential implications for assisted reproductive technology 
and demonstrated the underlying causes and therapies for infertility, recurrent miscarriage and 
pregnancy complications. In this thesis, Chapter 1 presents the state of the literature on early 
development in both humans and mice, including primordial germ cells (PGCs) development, 
pre-implantation development, implantation, early placentation and placental development. It 
also provides a review of two epigenetic regulation processes established in early development: X 
chromosome inactivation (XCI) and genomic imprinting. 
Chapter 2 describes the development of gonadal and extragonadal PGCs in humans, 
using immunofluorescence for germ cells markers and meiotic markers. Between first and second 
trimesters, there is a shift towards POU5F1−/DDX4+ germ cells in gonads. Human ectopic 
germ cells are present in both first- and second-trimester adrenals. Moreover, the asynchronous 
meiotic entry of human ‘adrenal’ and ‘ovarian’ germ cells highlights species-specific differences 
between human and mouse early gonadal and extragonadal gametogenesis.
Chapter 3 investigates the status of XCI in human pre-implantation embryos at single-
cell level, by analyzing online available RNA-seq data of human embryonic day (E)3-E7 embryos. 
Equal proportion of biallelic expression in “X-sub” (X-genes subject to X inactivation) and in 
autosomal genes suggests that both X chromosomes are active in E3 cells. Smaller proportion 
of biallelic expression in “X-sub” than in autosomal genes indicates that one X chromosome is 
inactive in E4-E6 cells and E7 trophectoderm (TE) cells, whereas it becomes reactivated in E7 
epiblast and primitive endoderm cells. In addition, combined human androgen receptor (AR)/
retinitis pigmentosa 2 (RP2) DNA methylation assay shows equal methylation of paternal and 
maternal alleles in female TE-derived cells, indicating non-imprinted X inactivation in human 
TE-derived cells, in contrast to the imprinted XCI in mouse TE-derived cells.
Chapter 4 describes in detail the invasion of human fetal extravillous trophoblast cells 
(EVTs) in maternal decidua and decidual vasculature during early pregnancy (W5.5-W12), using 
combined immunofluorescence and fluorescence in situ hybridization (FISH) for chrX/chrY to 
identify (male) EVTs unambiguously. This study serves as a reference for the entering of EVTs 
in maternal circulation (via decidual veins and lymphatic vessels) since W5.5, much earlier than 
previously accepted W8 (via decidual spiral arteries). The placental decidua interface of one 
Klinefelter syndrome embryo (mosaic 47,XXY and 46,XY) is also described. 
Chapter 5 studies the spatial imprinting pattern of IGF2/H19 in multiple-site collection 
of human first-trimester placental villi, using bisulfite DNA sequencing and allele-specific 
expression analysis of two informative non-CpG single-nucleotide polymorphism (SNP) sites 
allowing to discriminate the maternal and paternal alleles. Demethylated maternal alleles and 
methylated paternal alleles suggest a normal imprinting pattern of IGF2/H19 in multi-site 




Chapter 6 explores different consequences of Turner syndrome, using a mouse model 
that harbors either a single maternally inherited (Xm) or paternally inherited (Xp) chromosome, 
by a detailed analysis of morphology and glucose metabolism in E18.5 XmO and XpO placentas 
compared to wild type placentas. The significantly larger area occupied by glycogen cells in XpO 
placental outer zone (junctional zone, trophoblast giant cells and decidua) and the significantly 
higher expression of Ldha in XpO labyrinth zone suggest a more severe placental phenotype in 
E18.5 XpO placentas than in XmO placentas, with increased anaerobic glycolysis and underlying 
defects in oxygen availability in XpO placentas. 
Finally, Chapter 7 provides general discussion about the findings described in this thesis. 
This section also presents and discusses the future perspectives on embryo selection in assisted 
reproduction and new treatment strategies for infertility, pregnancy complications and sex 
chromosome related syndromes. 
Together, the work in this thesis provides novel insights into gonadal and extragonadal 
PGCs development in humans and XCI in human pre-implantation embryos. Also we have 
demonstrated the invasion of decidual vasculature by human extravillous trophoblast cells during 
early pregnancy, the spatial imprinting pattern of IGF2/H19 in human first-trimester placental 






Studies gericht op het begrijpen van preïmplantatie en placentale ontwikkeling bij mensen 
en muizen zijn belangrijk voor het optimalizeren van voortplantingstechnologien, het vinden van 
oorzaken en ontwikkelen van therapieën voor onvruchtbaarheid, terugkerende miskraamen en 
zwangerschapscomplicaties. In dit proefschrift, hoofdstuk 1 beschrijft de stand van de literatuur 
over vroege ontwikkeling in zowel mensen als muizen, inclusief de ontwikkeling van kiemcellen 
(PGC's), pre-implantatie, implantatie, vroege placenta vorming en placenta ontwikkeling. Het 
geeft ook een overzicht van twee epigenetische regulatieprocessen die zijn vastgesteld in de vroege 
ontwikkeling: X-chromosoom inactivatie (XCI) en genomische imprinting.
Hoofdstuk 2 beschrijft de ontwikkeling van gonadale en extragonadale PGC's bij 
mensen, gebruik makend van immunofluorescentie voor kiemcel- en meiotische-markers. 
Tussen het eerste en tweede trimester is er een verschuiving in de gonaden van POU5F1+/DDX4- 
kiemcellen naar POU5F1-/DDX4+ kiemcellen. Menselijke ectopische kiemcellen zijn aanwezig 
in de bijnieren in zowel de eerste als de tweede trimester. De asynchronie in timing van meiosis-
entry van menselijk kiemcellen (in the bijnier en ovarium) is een van de aspecten die verschillend 
is tussen mens en muis gametogenese.
Hoofdstuk 3 onderzoekt de status van XCI in menselijke pre-implantatie embryo's op 
enkel-cel niveau, door online beschikbare RNA-seq gegevens van embryo's van de menselijke 
embryonale dag (E)3-E7 te analyseren. Vergelijkend nivos van biallelische expressie in "X-sub" 
(X genen onderworpen aan X-inactivatie) en in autosomale genen suggereert dat er transcriptie 
is uit beide X-chromosomen, en dus dat beide actief zijn op E3. Minder biallele expressie in 
"X-sub" dan in autosomale genen geeft aan dat een van de twee X-chromosomen inactief is in 
E4-E6-cellen en E7 trophectoderm (TE) cellen, terwijl het wordt geactiveerd in E7 epiblast- en 
primitieve endodermcellen. Daarnaast blijkt uit een DNA methylatie assay (die de methylatie 
van humaan androgeen receptor en retinitis pigmentosa genen weergeeft) dat er gelijke 
methylering van paternale- en maternale-allelen in vrouwelijke TE-afgeleide cellen is. Dit toon 
aan dat random X-inactivatie in menselijke TE-afgeleide cellen is, in contrast met de imprinted 
X-inactivatie in muis-TE-afgeleide cellen.
Hoofdstuk 4 beschrijft in detail de invasie van menselijke foetale extravillous 
trophoblastcellen (EVT's) in de maternale decidua en de deciduale vasculatuur tijdens de 
vroege zwangerschap (W5.5-W12), met behulp van gecombineerde immunofluorescentie en 
fluorescente in situ hybridisatie (FISH) voor ChrX en ChrY om (mannelijke). It is noodzakelijk 
om EVT’s met zekerheid te identificeren. Deze studie toont dat er EVT's in de moedercirculatie 
(via decidale aderen en lymfatische vaten) aanwezig zijn vanaf W5.5, veel eerder dan via de 
deciduale spiraaladeren op W8. De placenta-decidua interface van een human embryo met 
Klinefelter syndroom (mozaïek 47, XXY en 46, XY) wordt in deze hoofdstuk ook beschreven.
Hoofdstuk 5 onderzoekt het imprinting status van het IGF2/H19 gebied op meerdere 




bisulfiet DNA sequencing en allel-specifieke expressie analyse van twee informatieve non-CpG 
SNPs die de paternale- en maternale-allelen kunnen onderscheiden. Gedemetyleerde maternale 
allelen en gemethyleerde paternale allelen suggereren een normaal imprintings status in het 
IGF2/H19 gebied in de verschillende placenta villi, zoals gevonden in het embryo.
Hoofdstuk 6 onderzoekt verschillende gevolgen van het Turner syndroom, met behulp 
van een muismodel dat zowel een enkel X chromosoom van maternaal (Xm) of paternaal (Xp) 
origine. Dit wordt bestudeerd door een gedetailleerde analyse van de morfologie, maar ook het 
glucose metabolisme, in zowel XmO en XpO E18.5 muizen placenta’s. Er is een aanzienlijk 
grotere gebied met glycogeencellen in de buitenste zone (junctionale zone, reuze trophoblast 
cellen en decidua) van XpO placenta’s en deen significant hogere expressie van Ldha in de XpO 
labyrintzone. Dit wijst op ernstiger afwijkingen in E18.5 XpO placenta’s dan in XmO placenta’s. 
Er is een verder een verhoogde anaërobe glycolyse en onderliggende defecten in zuurstof 
beschikbaarheid in XpO placenta’s. 
Ten slotte is hoofdstuk 7 een algemene discussie over de bevindingen die in dit proefschrift 
zijn beschreven. Toekomstperspectieven op embryo selectie bij geassisteerde voortplanting 
en nieuwe behandelingsstrategieën voor onvruchtbaarheid, zwangerschapscomplicaties en 
sekschromosoom gerelateerde syndromen worden behandeld.
Het werk in dit proefschrift geeft nieuwe inzichten in gonadale en extragonadale 
ontwikkeling van PGC's bij mensen en XCI in menselijke pre-implantatie embryo's weer. Ook 
presenteren we onze bevindingen over de invasie van deciduele vasculatuur door fetal EVT’s 
tijdens de vroege zwangerschap, het imprinting status van IGF2/H19 in menselijke eerste 
trimester placenta villi en tenslotte de gevolgen van het verschaffen van verschillende combinaties 
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